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SUMMARY 
Polymeric micro and nanoparticles are useful carriers for drugs and vaccines. 
During these applications, particles come into contact with macrophages of the 
reticuloendothelial system leading to their internalization. On one hand, uptake of particles 
by macrophages affects their ability to deliver therapeutics to the target cells. On the other 
hand, intracellular delivery of therapeutics is dependent on macrophage uptake in diseases 
or vaccines involving these cells. Previous research efforts have focused on identifying 
crucial particle physico-chemical properties like size, shape, surface chemistry and 
stiffness that are capable of enhancing drug delivery. However, as particle fabrication 
techniques advance to meet the growing need to develop complex particles for enhancing 
therapeutic delivery, identification of the inter-dependence between multiple physical 
properties on cellular interactions is critical. A major challenge with current particle 
fabrication techniques is the inability to tune each of their physical properties separately 
and thereby limiting investigation of influence of inter-dependent properties on cellular 
interactions.  Additionally, it is crucial to identify how individual properties alter cellular 
functions like cytokine production.  
To address these challenges, in this dissertation, we proposed a novel method that 
leverages the principles of self-assembly on soft templates to enable the tuning of multiple 
physical properties of particles while holding the surface chemistry constant.  This 
technique provides insight on how an individual particle property influences cellular 
interactions when they work in concert with other properties. We investigated the 
combined effect of physical properties size, shape and stiffness on macrophage interactions 
 xx 
in Fc receptor-mediated phagocytosis. Our results highlight, for example, how reducing 
stiffness works in a complex way when combined with size and shape. For spherical shaped 
particles, decreased stiffness works in tandem with increased size to reduce internalization. 
In contrast, decreased stiffness increases internalization of rod shapes relative to spheres. 
These particles highlight the interplay between size, shape and stiffness during 
phagocytosis by macrophages and can be leveraged to identify combinations of parameters 
that improve particle-based delivery to cells. 
In addition, this method enabled assembly of a phosphorylcholine co-polymer on 
microparticles in a single step, making it widely applicable and less time consuming 
compared to currently published covalent methods. We demonstrated that such a coating 
mechanism rendered the particles resistant to protein adsorption and phagocytosis by 
macrophages, two measures that are critical for use in biological systems. This highlighted 
the ability of this technique to be extendable to other polymers commonly used in the 
biomaterials community.  
While prior research and our studies helped in understanding the effect of particle 
physicochemical properties on the outcome of particle-macrophage interactions, it is 
unclear how macrophage functions like cytokine production are affected while presenting 
active ligands through altered physical properties. Moreover, it is unknown if geometric 
presentation through an altered shape can elicit differential macrophage cytokine responses 
and if similar responses can be noticed across varying ligands. Therefore, we investigated 
the influence of geometric presentation of varying ligands (BSA, IgG, OVA, CD200) 
facilitated by the manipulation of shape of the particle on macrophage inflammatory 
cytokine response. We investigated the influence of geometric presentation of varying 
 xxi 
ligands (BSA, IgG, OVA, CD200) facilitated by the manipulation of shape of the particle 
on macrophage inflammatory cytokine response- TNF-α. In addition, we examined the role 
of geometric presentation of different ligand densities between varying shapes. Further, 
this was correlated to TNF-α secretion and total particle association. This demonstrates 
how the geometric manipulation of diverse ligands through presentation on varying shapes 
alters inflammatory response in macrophage. 
 Overall, these studies enable identification of design rules for engineering cell 
interactions and responses. The identification of dominant properties such as size and the 
intricate interplay between stiffness and shape provide valuable information for the optimal 
design of advanced carriers to avoid or enhance macrophage internalization. Further, 
geometric presentation has been identified as an important design parameter that tunes 
cellular function like cytokine production. These findings are significant to both the 
biomaterials and the larger immunoengineering communities that actively employ various 
strategies involving particle properties and ligands to elicit immunological responses. 
These methods, techniques and results can be used to further fundamental research 
involving tunable particle-cell interactions and to inform particle design for specific 




CHAPTER 1. INTRODUCTION 
1.1 Approaches to synthetic carrier design 
Free drugs such as chemotherapeutics often suffer from solubility, toxicity and 
stability issues when introduced into the body1–3. There is a pressing need to identify 
vehicles for enhancing their therapeutic activity. This has led to a rapid progress in the 
design of synthetic carriers such as polymeric micro-, nanoparticles, liposomes and 
micelles4. However, the major hurdle in the success of these synthetic carriers lies in their 
ability to overcome biological hindrances when introduced into the body. In these 
applications, particles come into contact with biological fluids that contain a complex 
mixture of proteins that can adsorb on the particle surface5. This process, called 
opsonization, fouls their surface and can prevent desired interactions. Opsonization helps 
phagocytic cells of the reticuloendothelial system, like macrophages, to rapidly clear 
particles from circulation through phagocytosis. This process of phagocytosis faced by 
synthetic carriers often limits particles’ potential in biomedical applications. It has been 
established that biophysical particulate properties like size, surface chemistry, shape and 
mechanical properties influence phagocytosis6–10. 
  The motivation to use physical properties to elucidate the clearance mechanisms 
employed by macrophages  stems from the critical examination of native systems ranging 
from pathogens to cells11. Bacteria exhibit diverse properties like size, shape and surface 
chemistry, which contribute to their biological function. In addition, this also suggests that 
macrophages within our body must be able to recognize and clear such diverse bacteria. 
Cells like red blood cells possess unique biconcave shape and flexibility that enables them 
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to squeeze through tiny capillaries and any changes to these properties facilitates their 
clearance by macrophages upon aging12. Such examples have encouraged the design of 
synthetic particulates and the following sections illustrate the physico-chemical properties 
that have been explored in overcoming phagocytosis. 
1.2 Size 
Particles with sizes in the range of tens of nanometer to a few tens of microns have 
been studied actively for applications in drug delivery. Depending on the type of particle 
being made, numerous fabrication methods are being used including emulsion 
polymerization, microfabrication, self-assembly and jet breaking13–16. The processing 
parameters such as vortexing, sonication, stirring, nozzle diameter and flow rates, in 
addition to material and surfactant concentration play a prominent role in controlling the 
particle diameter17. The size of the particle in addition to other biophysical properties 
dictates in vivo functions such as circulation time, extravasation, internalization, targeting, 
clearance and uptake mechanism18,19. When introduced into the body intravenously, 
particles are cleared through varied mechanisms. Nanoparticles larger than 200 nm are 
cleared by the spleen through filtration where as those smaller than 100 nm have the ability 
to leave the blood vessels through fenestrations in the endothelial lining20,21 The leaky 
vasculature in the case of tumors, can enable these particles to take advantage of the 
enhanced permeation and retention effect provided the heterogeneity in tumor vasculature 
is known22,23. Microparticles in the size range of 1-5 µm are cleared by phagocytic Kupffer 
cells in the liver or trapped in the capillary beds. In the case of pulmonary administration 
microparticles in the range 1-3 µm are desirable as they can travel deep into the lungs24. 
However, this size range is susceptible to phagocytosis by alveolar macrophages thereby 
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limiting their applicability. Overall, for many routes of administration, particles greater 
than 500 nm are cleared by macrophages which is highly undesirable for biomedical 
applications25.  
This has prompted numerous studies to examine the effect of size on phagocytosis. 
Phagocytosis of polystyrene particles by mouse peritoneal macrophages was reported to 
exhibit maximal phagocytosis for an intermediate particle size of 1.7 µm6. In another study, 
despite the heterogeneity of neutrophils their phagocytic ability was found to decrease with 
increasing size of polystyrene microparticles in the range 0.5-8 µm26. Though these studies 
identified the optimum phagocytic range, no clear mechanistic insight into the process was 
given. Polystyrene particles in the size range 2-3 µm exhibited maximal phagocytosis7. 
This was attributed to the membrane ruffles that enable this specific size recognition of the 
particle by the macrophage. In addition, this range coincides with the general size range of 
bacteria, further highlighting the role of biophysical attributes in pathogen recognition27. 
1.3 Shape 
Various methods have been identified to produce diverse particle shapes, including 
mechanical stretching, soft lithography, microfluidics or self-assembly28–33. The local 
geometry of the particle at the point of attachment to the macrophages was established to 
dictate the outcome of phagocytosis8. It was shown that when a macrophage approached 
an opsonized polystyrene (PS) elliptical disc at its pointed end, internalization took place 
in a few minutes. Conversely, a macrophage attached to the flat region of the particle was 
not successful in internalizing even after 12 hours. In an extension of this study, high aspect 
ratio PS worms were prepared with the aim of minimizing local curvature and avoiding 
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uptake by macrophages34. Owing to the minimized curvature, these worms exhibited 6 
times lower internalization than spheres of the same volume. Studies have elucidated that 
the shape of a particle can influence attachment to and internalization by a macrophage 
independently 35. PS prolate ellipsoids have been shown to achieve maximum attachment 
compared to spheres and oblate ellipsoids. However, oblate ellipsoids exhibited higher 
internalization when compared to these two shapes. In another study, antibody-displaying 
micro-rods were shown to exhibit higher attachment and uptake compared to spheres in 
breast cancer cells36. 
 In line with the prior in vitro studies, long and flexible diblock copolymers 
composed of poly(ethylene oxide)-b-poly(ε-caprolactone) filomicelles evaded the 
reticuloendothelial system and persisted longer in circulation compared to spheres in 
vivo37. The same group found that prolonged circulating filomicelles loaded with drug 
paclitaxel can penetrate into the tumor stroma and produce greater and more sustained 
tumor shrinkage and tumor cell apoptosis38. Discoidal silicon particles were also shown to 
exhibit unique tumbling and margination dynamics that enhanced their interaction with 
vessel walls than spherical particles39. These studies highlight that the shape of a particle 
is another essential property that plays an important role in particle adhesion, distribution 
and cell internalization. 
1.4 Surface Chemistry 
The major limitation of micro and nanoparticles is their inability to reach the diseased 
sites at therapeutically relevant doses owing to nonspecific uptake by the cells of the 
reticuloendothelial system; macrophages5,40. This nonspecific process is initiated by the 
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opsonization of proteins on the surface of the particles, involving plasma proteins such as 
serum albumin, apolipoproteins, complement components and immunoglobulins. This 
adsorption is dependent upon the particle surface charge, surface chemistry and size. Not 
only does opsonization enhance uptake by macrophages it is also detrimental to active 
targeting motifs present on the surface that often get masked by the adsorbed protein 
corona. Thus tuning the surface chemistry is critical to avoid opsonization and macrophage 
uptake and enhance the ability to retain targeting to diseased cells. 
The surface charge of the particle is known to influence the outcome of phagocytic 
process41. Particles that are neutral in charge at physiologically pH avoid recognition by 
macrophages while those with high positive or negative charge are recognized by these 
cells. Another aspect that contributes to recognition by macrophages is particle 
hydrophobicity. Hydrophobic particles are preferentially coated by opsonins such as 
immunoglobulin, complement, albumin that aide in clearance of these particles by 
macrophages42,43.  Therefore, hydrophilic coatings on particles is a common approach to 
delay such a recognition. PEGylation is the most common method to delay opsonization 
and increase the circulation time of particles44. However, of late there is growing evidence 
of generation of anti-polyethylene glycol (PEG) antibodies in the body in response to these 
materials45,46. Alternative zwitterionic polymers such as poly(phosphorylcholine), 
poly(sulfobetaine), and poly(carboxybetaine) have been observed to delay protein 
adsorption and enhance the circulation times when coated on particles47. In addition to 
synthetic polymers, biomimetic stealth coatings utilize mechanisms from cells to avoid 
phagocytic uptake. Cell mimics have been created by using cellular membranes to cloak 
nanoparticles48–50. These particles have the physical properties of the underlying synthetic 
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nanomaterial but the native membrane surface enables them to avoid opsonization, delay 
uptake by mononuclear phagocyte system, have long circulation times, bind to target cells 
and deliver a therapeutic load. Another approach is to use specific ligands to target 
particular cell receptors. Self-ligands such as, CD47 signal macrophages not to internalize 
cells that present this molecule on their surface. Peptides from CD47 were computationally 
designed and immobilized on the surface of nanoparticles51. These peptides substantially 
prolonged particle circulation by delaying phagocytic clearance. On the other hand, ligands 
such as immunoglobulin G (IgG) when displayed on particles can be used to enhance 
recognition and uptake by macrophages through interactions with the Fc receptor7,9,52. 
These studies highlight the role of surface chemistry and functionality in tuning 
interactions with macrophages.  
1.5 Stiffness 
Particle stiffness is an emerging physical property of particles. Its role in influencing 
cellular interactions is still unclear and depends on the materials, cells and range of 
stiffness. For the case of immune cells and macrophages, several studies have shown that 
hard particles are internalized more than soft particles. Soft poly (l-glutamic acid)-CpG 
capsules (800 nm) associated less with plasmacytoid dendritic cells than hard capsules53. 
Similar results were observed in the case of tannic acid/poly(vinylpyrrolidone) 
(TA/PVPON) soft cubical and spherical capsules54, PEG hydrogel spheres55, 
polyacrylamide spheres9, and polylactic-co-glycolic acid (PLGA) -PEG lipid disks56. 
However, in another study,  N,N-diethyl acrylamide and 2-hydroxyethyl methacrylate 
hydrogel particles (~170 nm) of intermediate elasticity were internalized more than those 
at either extreme57. For the case of cancer cells, softest hyaluronic acid capsules (2.4 µm) 
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exhibited highest association, both internalization and attachment by HeLa cells, compared 
to stiff capsules of similar size58. Similar results were observed in the case of dextran sulfate 
sodium salt and poly-L-arginine hydrochloride or poly(sodium 4-styrenesulfonate) and 
poly(allylamine hydrochloride) based capsules (sizes 4.1 and 4.7 µm), where soft capsules 
were internalized and transported to lysosomes faster than hard capsules in HeLa cells59. 
On the other hand, for PEG hydrogel bare or ICAM-1 functionalized spheres (200 nm) 
hard particles were internalized more than soft particles of similar size by 4T1 breast cancer 
cells55. From these cases it is clear that stiffness plays a complex role in cellular interactions 
and that it may be highly dependent on the cell type and the other properties of the particles 
being studied, such as size, chemistry or shape.  
1.6 Layer-by-layer engineered capsules 
Layer-by-layer (LbL) technique has the ability to tune particle properties based on 
the choice of polyelectrolyes, their properties and the interaction between the 
polyelectrolytes involved 60. This method can form multilayer capsules after the deposition 
of polyelectrolytes on the surface of colloidal template particles, followed by removal of 
the sacrificial template.  These capsules retain the size and shape of their template due to 
interactions between the polyelectrolyte layers such as electrostatic interactions61, 
hydrogen bonding62, hydrophobic interactions63 and covalent coupling64.  Another 
attractive feature of the method is its ability to incorporate a wide range of molecules such 
as organic dyes, quantum dots, biologically active molecules, electroactive polymers65,66. 
This flexibility in choice of template, interactions and materials to be assembled has been 
beneficial for drug delivery applications. The modular nature enables incorporation of 
biologics like proteins, peptides and nucleic acids into the intermediate layers. This is 
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particularly advantageous considering the high loadings achieved by this process through 
charge compensation of the material. In addition, the outermost layer of the assembly can 
be chemically modified to impart functionalities that can be useful in targeting or provide 
stealth properties for systemic delivery in the blood stream. This versatility in properties 
and function is difficult to achieve in traditional polymeric particles. Thus, this modular 
technique is promising in developing multifunctional capsules for a wide range of diseases 
based on the choice of templates and type of interactions. 
The templates for capsule formation through LbL, can be broadly classified into 
hard or soft templates. Inorganic particles made from CaCO3 67, silica64, gold68 are 
commonly used hard materials in LbL applications. Soft templates are made from organic 
particles such as PS or PLGA. In addition to particles, LbL has also been performed on red 
blood cells and E.Coli.69,70 The diversity of templates and the choice of coating materials 
has given rise to wide variety of LbL multilayered particles of different shapes, sizes and 
chemical composition. However, one is often restricted to choose between the size and 
shape of template that is readily available.  
In addition to template choice, the type of interaction driving the formation of these 
capsules affects the final properties and applications of the capsules. Capsules made from 
hydrogen bonding interactions enables creation of different chemical composition of 
multilayers different from the traditionally used electrostatic interactions60. Single 
component capsule shells can be made by simple disruption of hydrogen bonding and 
removal of one of the polyelectrolytes. The ability to cross link such capsules can impart 
stability with pH dependence64. In addition, shells responsive to different environmental 
pH can be produced based on the choice of the polyelectrolyte combination71. The 
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intermolecular hydrogen bonding can also be used to alter the mechanical properties of the 
shell. For the case of (poly(methacrylic acid) /PVPON-co-NH2)7 , the shell stiffness was 
altered based on the pH the multilayer was exposed to71. Similarly in the case of TA/ 
PVPON capsules, hydrogen bonding between the layers of capsules was also shown to 
substantially reduce elasticity in comparison to traditional LbL capsules based on 
electrostatic interaction72.  
Overall, LbL is a versatile technique that enables control of the physico-chemical 
properties of particles and can be used to understand particle interactions with cells. The 
influence of shape of capsules has been investigated though the trends are not clear. In the 
case of poly(methacrylic acid) (PMA) capsules with HeLa cells, spherical capsules were 
internalized more than rod shaped capsules73. In another study, bowl-like bovine serum 
albumin coated (BSA) poly-(allylamine hydrochloride)/poly-(styrenesulfonate) 
(PAH/PSS) capsules were found to mainly attach to cells from the convex-side and were 
subsequently internalized. It was hypothesized that less energy expenditure is required for 
membrane deformation in this geometry and that facilitates enhanced uptake of these 
capsules over spherical shapes74. Bio-inspired red blood cell discoid PMA capsule particles 
exhibited lower internalization compared to their spherical counterparts in endothelial, 
breast cancer and macrophage cells75. The elasticity of LbL capsules has also been 
observed to affect interactions with cells, though in a cell type specific manner. Soft poly 
(l-glutamic acid)-CpG spherical  capsules (800 nm) associated less with plasmacytoid 
dendritic cells than hard capsules53. In the case of, (TA/PVPON) soft cubical and spherical 
capsules exhibited lower internalization when compared to their stiffer counterparts with 
macrophage cells 54. The contrary trend is observed in the case of cancer cells, where soft 
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particles are internalized more than hard particles. This was the case for hyaluronic acid 
spherical capsules (2.4 µm) 58, dextran sulfate sodium salt and poly-L-arginine 
hydrochloride (4.1 µm), and poly(sodium 4-styrenesulfonate) and poly(allylamine 
hydrochloride) (4.7 µm) based spherical capsules59. 
In addition to understanding the role of particle-cell interactions, LbL engineered 
capsules are developing novel immunotherapies. Ovalbumin (OVA) containing PMASH 
capsules were internalized by antigen presenting cells resulting in presentation of OVA 
epitopes and subsequent activation of OVA-specific CD4 and CD8 T cells in vitro76. These 
capsules were further shown to exhibit at least 6-fold greater proliferation of OVA-specific 
CD8 T cells and 70-fold greater proliferation of OVA-specific CD4 T cells in vivo 
compared to the equivalent amount of soluble OVA, which could be beneficial for 
vaccination. LbL capsules have also been constructed entirely from immunologically 
active adjuvant and antigen polymers in order to simultaneously deliver both77. Sacrificial 
gold nanoparticles were functionalized by the deposition of the anionic adjuvant 
polyinosinic–polycytidylic acid (polyIC) and a cationic version of the SIINFEKL model 
peptide antigen. In vitro, this vaccine was able to induce dendritic cell maturation and 
antigen-specific CD8+ T cell proliferation in a co-culture experiment, matching the activity 
of the free adjuvant/antigen pair. However, intradermal injection of this vaccine into mice 
was able to promote 5-fold stronger antigen-specific CD8+ T cell proliferation than that of 
freely administered polyIC and antigen. These promising studies highlight the applicability 
of LbL method in immunotherapy. Additionally, targeting ligands can be incorporated to 
enhance interactions with specific cells of interest. LbL technique confers a high degree of 
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modularity, versatility and compositional heterogeneity to particles and has the potential 
to provide a unique platform to contribute to immuno-engineering.  
1.7 Design strategies to tune cell responses  
Immuno-engineering is an emerging field that seeks to understand and manipulate 
the immune system. Fundamental knowledge of the immune system is necessary to create 
molecules, materials, and strategies that can alter immune responses in a disease setting. In 
such a setting, immune responses in the body are initiated between cells, cell and infectious 
agent, or cell and endogenous molecules. During infection, pathogens activate the innate 
components of the immune system that help in controlling the infection. When the infection 
is not contained, an adaptive immune response is initiated. During such immune responses, 
contact based interfaces are often formed between immune cells including antigen 
presenting cells (APCs), B cells, T cells and phagocytes78. This interface sustains contact 
dependent receptor engagement, polarization of molecules in partner cells, and confined 
release of secreted products to partner cells79. Contact independent mechanisms also 
contribute to the stimulation or suppression of cells through secretion of signaling 
molecules by the source cells. This indicates that cell based interactions provide 
opportunities to direct immune responses.  
Native and synthetic particulates can be engineered to achieve such responses 
through the formation of new immune-material interfaces. Native materials, such as 
extracellular vesicles, are an emerging class of materials ripe for engineering. These 
particles contain immune-active molecules and also display functional surface molecules 
that can be used for targeting and interacting with cells80. Synthetic particulates like 
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biomimetic materials are inspired from nature to recapitulate a natural immune function. 
These particulates are capable of interacting with cells and eliciting specific cellular 
responses by manipulating parameters such as geometry, presentation of ligands, and 
incorporation of adjuvants. In addition to replication of natural function, inherent material 
properties can also achieve a desired function. A wide variety of materials including solid 
polymer particles, liposomes, polymer micelles, gold, carbon materials, silicon oxide are 
also being used for biological applications. A major drawback of inorganic materials based 
particulates is their biodegradability81.  Though natural particulates and biomimicry are 
valuable tools, the ability to create designer molecules with novel combinations of 
functions can access signaling and interactions that are not possible otherwise. These 
synthetic molecules may be more cost effective with advantages of precise control, 
enabling highly specific and tunable interactions with targets. The following sections deal 
with the design strategies of synthetic particles and the role of their inherent properties to 
tune cellular responses.  
1.7.1 Biomimetic materials  
 Biomimetic strategies are ways to recreate interactions of cells with other cells, 
pathogens or molecules with the ability to tune the degree of complexity. This involves 
understanding key features of cellular communication such as antigenic components, cell 
entry mechanisms, surface ligands, and tolerization. This section highlights biomimetic 
particle strategies based on these features. Some designs seek to recapitulate the structure 
and chemistry of cell-cell, cell-particle, or cell-molecule interactions, with the hypothesis 
that function will follow structure. Other approaches are inspired by the natural function 
but design to achieve function directly, not necessarily with the same structure used in the 
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native system. In the examples below a wide range of particle physicochemical properties 
are used to elicit desired immune responses.  
1.7.1.1 Cell Mimics 
Cell mimics are created by using cellular membranes to cloak nanoparticles or 
preparing cell ghosts through a combination of hypotonic treatment and extrusion 
processes50,82. Extraction of cellular membranes has been incorporated in various 
applications. Cellular membranes contain diverse antigenic profiles and specific surface 
molecules that enable targeting. These membranes can be utilized to alter immune 
responses by their incorporation on nanoparticles (NPs). Cancer cell membrane coated NPs 
retain their membrane bound tumor antigens82. These particles, in combination with an 
adjuvant, were shown to induce anti-cancer immune responses such as stimulation of 
cytotoxic T lymphocyte (CTLs). Moreover, these coated particles were shown to use the 
homotypic binding mechanism, by which adhesive domains on tumor cells form 
multicellular aggregates, and target cancer cells in vitro. 
Membrane isolation and cloaking was further extended to red blood cells (RBCs). In 
autoimmune diseases such as type II, type III, and type IV immune hypersensitivity, 
autoantibodies against RBC membrane components are produced in the body49. 
Nanoparticles that present natural RBC membrane and its associated surface antigens that 
are involved in antibody-mediated RBC clearance were prepared. RBC cloaked 
nanoparticles were shown to intercept the autoreactive antibodies of type II immune 
hypersensitivity reaction. These particles acted as ‘antibody decoys’ that bind to anti-RBC 
antibodies, protecting circulating RBCs. In another application, nanosponges made of RBC 
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membrane coated nanoparticles provided a platform to absorb pore- forming toxins that 
are common in bacterial infections and lyse host RBCs83. 
In contrast, “un-natural killer cell” mimics were made by functionalizing leukocytes 
with liposomes presenting E- selectin (ES) and TNF related apoptosis inducing ligand 
(TRAIL)84. ES and TRAIL are often used to target cancerous cells, and natural killer (NK) 
cells that take part in immunosurveillance present TRAIL on their surfaces. ES and TRAIL 
coated liposomes that mimic NK cells bound leukocytes via selectins on the cell surface 
under shear flow conditions. These liposomes induced apoptosis of circulating cancer cells 
in mice. The high compressive force experienced by the cancer cell upon collision with the 
liposome functionalized leukocytes induced flattening and binding of ligands on the cell 
surfaces.  
Similarly, membrane receptors were immobilized on an artificial, cell-like protocell 
to prevent infection. Protocells bearing the entry receptor of henipavirus in lipid bilayers 
were supported on silica particles85. The protocells specifically and renewably inactivated 
henipavirus envelope glycoprotein pseudovirus particles. A protein, Ephrin-B2, on the 
surface of the particle allowed fusion of the viral envelope with the protocell. The 
protocells were hypothesized to disarm the virus by deactivating a protein that causes the 
virus to enter the cell. Such biomimetic combination approaches, containing both antigenic 
information and natural surface properties of cells, could lead to new therapeutics for 
disease intervention. 
In another application, biomimetic leuko-polymersomes were assembled from block 
co-polymers and functionalized with sialyl Lewis X (selectin) and an antibody against 
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intercellular adhesion molecule 1 (ICAM-1, integrin)86. These polymersomes bound 
exclusively to inflamed HUVECs. By optimizing the ratios of selectin and integrin receptor 
mimics on the surface of the polymersomes, selective binding to inflamed sites and 
mimicry of leukocyte adhesion was achieved. These can be used to selectively target sites 
of inflammation and has applications in imaging and drug delivery. 
Cell mimetic nanoparticles produced through membrane coating recreate the cellular 
interface to enable complex cellular processes initiated at the membrane. These particles 
have the physical properties of the underlying synthetic nanomaterial and are able to avoid 
opsonization, delay uptake by mononuclear phagocyte system, have long circulation times, 
bind to target cells and deliver a therapeutic load48–50. In addition to the above-mentioned 
applications this technique is also being extended to develop vaccines for bacterial 
infections87. The prospects of this membrane coating application are exciting but the 
scaling of this technique and immunogenicity needs to be addressed. Synthetic versions 
can address the issue of scalability but in vivo testing of these still needs to be pursued.  
1.7.1.2 Pathogen Mimicking 
Pathogens such as bacteria and viruses evade and manipulate the immune system 
to induce favorable interactions with target cells. Particulate forms of antigen and co-
delivery of danger signals and antigen have been identified as critical parameters for 
pathogen mimics for vaccine development. Nanoparticles composed of multilamellar lipid 
vesicles with antigen entrapped and expressed on the surface were shown to elicit a strong 
humoral response88. This strong response was attributed to the formation of germinal B 
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cell centers near the NP depot that facilitated B cell responses. In addition, activation of 
follicular T cells supported the induction of strong humoral response.  
In another study, polyelectrolyte multilayer capsules composed of dextran sulfate 
and poly-L-arginine with surface-bound CpG adjuvant were engineered to mimic 
pathogens89. These CpG coated and OVA encapsulated capsules induced antibody, Th1 
and CTL responses. In a similar approach, malaria antigenic tri-epitope peptide 
incorporated on a polypeptide layer-by-layer microparticle was shown to induce 
neutralizing antibodies and malaria-specific T cell responses in vivo90. These examples 
suggest understanding the synergistic effect of various pathogen structures and 
composition can enhance the effectiveness of vaccines. Lipid enveloped PLGA micro and 
nanoparticles modified with adjuvants monophosphoryl lipid A (MPLA) and α-
galactosylceramide in the layers and OVA antigen on the surface were created to mimic 
pathogens91. These particles were shown to elicit strong immune responses such as 
antibody titers and CD8+ T cell stimulation at doses lower than conventional doses of alum 
or protein-adjuvant solutions.  
In another study, the effect of shape on antigen presentation on PS particles was 
investigated. Ovalbumin conjugated rod shaped polystyrene particles were shown to 
induce a Th2 type immune response against ovalbumin while their spherical counterparts 
induced a Th1 type response in vivo92. In another study, mannose functionalized poly(DL-
lactide)-b-poly-(acrylic acid) long cylindrical nanoparticle induced inflammatory response 
in macrophages by the production of IL-6, stronger than spherical or short cylindrical 
nanoparticle93. These examples suggest the ability of immune cells to respond differentially 
to biological signals when biophysical attributes of presentation are altered. These studies 
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emphasize the need to explore the design strategy of ligand presentation on particulates for 
eliciting an immune response. 
1.7.1.3 Artificial Antigen Presentation  
Artificial antigen presenting cells (aAPCs) can be used for both adoptive and active 
immunotherapy. These aAPCs should be able to create a physical interface with T cells to 
present antigen, co-stimulatory factors, and stimulate cytokine release94. aAPCs can 
activate and expand T cells ex vivo which are then adoptively transferred into a patient95,96. 
They can also be injected in vivo to achieve T cell activation. RAFTsomes are liposomes 
derived from enriched major histocompatibility complex (MHC) class II lipid rafts of 
membranes from DCs that were stimulated with antigens97. They elicit CD4+ T cell 
priming, antibody production, and antigen specific responses in vivo. This shows that 
membrane microdomains enriched in MHC-peptide complexes alone, without co-
stimulatory factors, can achieve an immune response.  
PS bead aAPCs have been functionalized with MHC class I tetramers and co-
stimulatory molecules98. When coupled with melanoma associated self-antigen and 
injected intravenously and subcutaneously, they elicited specific CTL responses and 
delayed tumor progression in a melanoma model of naïve and antigen-primed mice. 
However, biosafety and organ toxicity is a concern with these systems. 
Nanoscale iron-dextran and quantum dot particles coupled with MHC-Ig dimers 
and anti-CD28, were effective in T cell stimulation99. These nanoparticles induced antigen 
specific T cell responses in vitro and anti-tumor activity in vivo. This was attributed to the 
use of MHC-Ig dimers with a flexible hinge region and the ability of MHC-dimers to 
enhance TCR and MHC interactions. Unlike micro aAPCs, these nano-aAPCs were shown 
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to localize in the lymph nodes and distribute away from the injection site. In an extension 
of this study, these iron- dextran paramagnetic nano-aAPC were shown to facilitate 
magnetic-field induced T cell activation100. The magnetic field caused aggregation of these 
paramagnetic aAPC, which was associated with increased T cell receptor (TCR) clusters 
and T cell activation in vitro. This technique was suitable to activate naïve T cells, antigen-
specific T cells and such activated T cells were shown to inhibit tumor growth in a 
melanoma adoptive immunotherapy in vivo model. These studies are the first 
demonstration of nanoscale aAPC particles with applications in adoptive immunotherapy 
through magnetic-field induced nano-aAPC based antigen specific T cell expansion. 
Janus particles have also been used as aAPCs to activate T cells. Micron-sized silica 
particles with a “bull’s eye” pattern, that resembles the immunological synapse were 
fabricated101. Anti-CD3 was enriched in the central domain and surrounded by fibronectin 
molecules for adhesion to mimic the native pattern. A reversed pattern with fibronectin as 
a central domain surrounded by anti-CD3 was also fabricated. The reverse “bull’s eye” 
pattern enhanced polyclonal T cell activation over the native “bull’s eye”, which performed 
slightly better than particles coated with fibronectin. This enhanced activation was 
attributed to a combination of spatial organization and increased surface coverage by anti-
CD3. 
While Janus particles with the “bull’s eye” pattern captured the importance of 
ligand spatial organization to enhance interactions between aAPCs and T cells, geometry 
of aAPCs has also been identified as a crucial parameter for such interactions. Ellipsoidal 
aAPCs displaying MHC-Ig dimers and anti-CD28 were shown to activate CD8+ T cells in 
vitro better than spherical aAPCs102. This improved activation was demonstrated to be 
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dependent on the shape of aAPCs and not differences in the density of the ligands on the 
surface. These ellipsoidal aAPCs were effective in increasing the survival of mice 
compared to spherical aAPCs in a subcutaneous melanoma tumor model. 
The previous aAPC systems primarily incorporate antigen recognition and co-
stimulation but not cytokine release. PLGA micro-aAPCs with peptide-MHC, co-
stimulatory ligands and encapsulated IL-2 were fabricated to replicate all the key features 
of APCs103. CD4+ and CD8+ T cells were stimulated to a greater extent when co-cultured 
with these aAPCs than aAPCs that lack encapsulated IL-2 but were supplemented with the 
cytokine exogenously. Paracrine delivery of IL-2 upon aAPC contact with T-cell resulted 
in increased accumulation of synaptic IL-2 and increased proliferation of CD8+ T cells in 
vitro than exogenous administration of IL-2. Furthermore, these T cell responses were 
found to be dependent on the sustained release of the cytokine and proximity between 
aAPCs and T cells. 
aAPCs can also be used to activate T cells with chimeric antigen receptors (CARs). 
Adoptive transfer of T cells with CARs that recognize specific tumor antigens has been 
shown to be effective in tumor immunotherapy104. However, this method requires aAPCs 
to be tuned to the specific antigen recognized by CARs. A universal aAPC was developed 
with K562 lymphoblast cells expressing a ligand directed towards a conserved extracellular 
domain on CARs105. This contributed towards activation of CAR modified T cells, 
independent of their antigen specificity, but preserved their antigen specificity. These 
strategies and design parameters provide insight for the development of targeted therapies 
that circumvent the need for natural APCs to initiate immune responses. 
1.7.1.4 Specific Ligand Immobilization  
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APCs present antigen to T cells within an immunological synapse that forms 
between the two cells. Adhesion molecules on these cells aid in the formation of this 
synapse106. Synthetic peptides LABL and cIBR have been developed to bind receptors 
ICAM-1 and lymphocyte function associated antigen (LFA-1) on DCs and T cells, 
respectively107. Functionalization of LABL peptides on NP inhibited binding of T cells to 
DCs through blockade of ICAM-1. Similarly, cIBR-NP pre-treated T cells interacted with 
DCs to a lesser extent than untreated T cells. These peptide-functionalized nanoparticles 
can be used to interfere with the maturation of DCs or T cell expansion.  
T cells expand when activated with antigen and co-stimulatory signals. Activation 
of T cells is mediated through the TCR-CD3 complex. On naïve T cells, TCRs are present 
in nanoclusters on the cell surface that oligomerize into microclusters upon activation108. 
Anti-CD3 functionalized quantum dots exploited this difference in TCR clustering to 
selectively activate antigen-experienced T cells. The sensitivity of TCR clusters in antigen-
experienced cells is greater than naïve T cells, which initiates this response. These 
nanoparticles enhanced antigen-specific T cell responses in vivo and exhibited increased 
recall response upon challenge. This strategy could also be extended to other clustered 
receptors such as CD20 on B cells. 
CD200R is expressed on immune cells and is an inhibitory immune receptor. It 
associates with its ligand CD200, a known immune-modulatory protein109. CD200 
functionalized 28 µm polystyrene microbeads bound CD200R on macrophages and 
reduced activation and inflammatory cytokine release. These particles also reduced 
inflammation in vivo. This strategy could be applied to other types of biomaterials to reduce 
the foreign material immune response. 
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1.7.1.5 Tolerance Induction  
Apoptotic cells and their debris are removed from the body by immune cells 
without activation of the immune system110. When these antigens are processed by APCs 
in the absence of an inflammatory signal, tolerance is induced. This processing is a key 
mechanism through which peripheral tolerance is maintained. Apoptotic protein/peptide 
antigens covalently coupled to splenocytes (Ag-SPs) were shown to induce antigen-
specific T-cell tolerance111. Upon intravenous administration, Ag-SPs initiated IL-10 
production by marginal zone (MZ) macrophages. IL-10 production was found to regulate 
the expression of programmed death ligand-1 (PD-L1) on MZ macrophages, which was 
critical for tolerance induction. Regulatory (Treg) cell induction was also confirmed. In a 
recent Phase I clinical trial for multiple sclerosis, myelin peptide antigens were coupled to 
autologous peripheral blood mononuclear cells112. A reduction in myelin-specific 
autoreactive T cell response was observed.  
A modular biomolecular approach was developed to induce immunological 
tolerance by exploiting apoptotic cell carriers. A targeted antigen that binds to the protein 
glycophorin-A on the surface of mouse erythrocytes was engineered113. This antigen 
induced anergy when processed by APCs following erythrocyte-apoptosis. In a mouse 
model of autoimmune diabetes, deletion of autoreactive T cells was achieved when β-cell 
antigen was bound to erythrocytes through a designed antibody construct. This technique 
could also be applied to other antigens for tolerization. 
Particle based tolerogenic approaches are also being pursued to take advantage of 
their large-scale fabrication. Encephalitogenic antigen peptide covalently coupled to 
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polystyrene or biodegradable PLGA microparticles, was shown to induce T cell tolerance 
in a mouse model of experimental autoimmune encephalomyelitis114. MZ macrophages 
internalized these particles through scavenger receptor, macrophage receptor with 
collagenous structure (MARCO), and played a key role in regulating the response. This 
tolerance induction depended both on T cell anergy and activity of Tregs. In a related 
approach, iron oxide nanoparticles were coated with different peptide-MHC complexes to 
blunt the polyspecific autoimmune responses in a type 1 diabetes model115. Nanoparticles 
coated with disease-relevant peptide-MHC complexes were also shown to expand cognate 
“autoregulatory” T cells. This antigen experienced CD8+ autoreactive T cells were found 
to suppress the activation and recruitment of other non-cognate specificities. This  
technique can be extended to other diseases by incorporating relevant antigen. 
Extending the particle strategy, synthetic nanoparticles encapsulating protein or 
peptide antigens and tolerogenic immunomodulator rapamycin were shown to induce 
tolerance towards the antigen116. These nanoparticles were effective in models such as 
allergic hypersensitivity disorder, multiple sclerosis, and hemophilia A. Rapamycin has 
been established to induce tolerance even in the presence of inflammation. Similarly, these 
nanoparticles retained their tolerogenic potential even when co-administered in the 
presence of antigen and TLR agonists. This technique can address the issue of anaphylaxis, 
where antigen administration during inflammation often leads to disease exacerbation.  
A biodegradable PLGA nanoparticle platform was developed by an emulsion 
process using poly (ethylene-co-maleic acid) as a surfactant117. These particles were 
investigated for their ability to couple to antigen, and safety and protection in a mouse 
multiple sclerosis model. The incorporation of the surfactant into the PLGA particle 
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synthesis was shown to mitigate the disease, relapses and minimize epitope spreading 
during intravenous administration. These particles had superior performance than 
commercially available nanoparticles but the mechanism has not yet been established. 
These antigen-coupled particles were demonstrated to be safe and not induce an 
anaphylactic reaction. This biodegradable nanoparticle platform can be extended to other 
diseases by changing the antigenic epitopes. 
 Biomimetic materials take advantage of the physicochemical properties of nano and 
micro materials. The nanomaterials, owing to their size, can enable targeting of specific 
cell types such as those in the lymph nodes118. These materials can also be tuned to mimic 
cells or pathogens while retaining a key advantage of synthetic materials, mass production. 
They represent an exciting area where engineering principles can be applied to biologically 
inspired design to achieve immunologically active materials. 
1.7.2 Material properties control immune cell responses  
While immune engineering of synthetic materials through biomimicry is an active 
area of research, there is growing evidence of materials having intrinsic properties that 
influence immune responses. Inflammatory responses in immune cells are initiated by 
particulate matter like PLGA119, gold120 , aluminium121 and mesoporous silica rods 
(MSR)122 through the activation of inflammasome. The choice of the material and their 
physicochemical attributes seem to contribute to such activation. The surface curvature or 
texture of polystyrene-block-poly(ethylene oxide) microparticles was also shown as a 
contributing factor in activation of inflammasome in immune cells123. A combination of 
shape and hydroxyl surface chemistry was shown to cause inflammatory responses in the 
case of aluminium based particles121. Properties like shape are also critical in the activation 
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of inflammasome; rod shape was more effective than cubical or spherical virus 
functionalized gold nanoparticles120.These studies suggest that not only do material 
properties alone or in combination with other biological molecules influence immune cell 
responses. 
Shape of the particle can also lead to inflammatory responses in immune cells 124. 
Rod shaped particles were shown to stimulate macrophages more than spherical shaped 
PMA polyelectrolyte capsules. While the mechanism in this case is not yet clear it can be 
through altered processing of these shaped particles by cells upon uptake. Like shape, 
hydrophobicity of particles also contributes to activation of innate and adaptive immune 
responses. Tuning the hydrophobicity of antigen encapsulated poly( glutamic acid) 
correlated with immune cell activation and cellular immunity in vivo125. In another study, 
hydrophobicity of gold nanoparticles was shown to activate immune cells in vitro and 
influence innate immune response in vivo126. 
Another way through which the innate immune system can be activated is through 
the complement system, and surface chemistry of particles plays a major role in this 
activation. Hydroxylated pluronic-stabilized poly)propylene sulfide) nanoparticles were 
shown to activate the complement system and induced a danger signal that drove dendritic 
cell maturation127. In addition, when conjugated with antigen on the surface these particles 
were shown to enhance cellular immunity. In an extension of this study, surface charge of 
the particles was shown to modulate the complement activation128.  
Another area where particle properties are being explored is for cytosolic delivery 
of antigens to facilitate cross-presentation. Acetalated dextran nanoparticles encapsulated 
with OVA were shown to enhance MHC-I presentation by an order of magnitude than 
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PLGA particles129. This was attributed to the tunable degradability of these particles in 
comparison to PLGA particles. Moreover, the degradability of these particles tuned the 
type of pathway for MHC-1 presentation. This study highlights how material properties 
can be explored to direct immunological processing and presentation.  
Material properties can also contribute to the induction of autophagy that can be 
used to trigger an adaptive immune response. The induction of autophagy is an attractive 
mechanism particularly for diseases like cancer. Alumina nanoparticles conjugated with 
antigen and not metallic iron oxide nanoparticles were shown to utilize autophagy as a 
mechanism in dendritic cells to cross-present antigen to T cells in vitro130. These particles 
also promoted anti-tumor responses in vivo when conjugated to tumor antigen or tumor cell 
derived autophagosome. In another study, the surface functionalization of SWCT was 
being explored to induce autophagy131. Carboxylic acid functionalized SWCT were shown 
to induce autophagy in human lung adenocarcinoma cells. This surface functionalization 
was also shown to cause acute lung injury in vivo.  
While the above examples illustrate the immunostimulatory properties of particles, 
their role in modulation is also being explored. The role of surface charge of polystyrene 
beads in modulation was highlighted in inflammatory disease models including colitis, 
peritonitis, and myocardial infarction132. It was established that negatively charged 
spherical particles without any specific antigen are engulfed by inflammatory monocytes, 
which then migrate to spleen resulting in their apoptosis and dampening of inflammation. 
The above studies highlight the need to understand the reaction between a synthetic 
particle and the host system by characterization of relevant inflammatory mediators. This 
is critical especially when the particle is similar to pathogens in properties like size and 
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surface chemistry. While this replication in material properties is favorable for applications 
involving stimulation, it might have a counter effect in cases involving modulation.  
As the field of immune-engineering grows, so will opportunities to manipulate 
immune interfaces with synthetic materials. Advances in understanding of immune cell 
function and signaling in health and disease will create new sources of bioinspiration and 
new ideas for therapeutic interventions. The exploration of intrinsic properties of synthetic 
materials will lead to new avenues in shaping immune responses. These will be coupled 
with improving chemical synthesis and molecular control, nano and microparticle 
fabrication, and practical scale up and production.  
1.8 Motivations and Objectives 
Most of the studies discussed in the previous sections have observed the effect of 
either one or two physical properties on cellular interactions. However, as particle synthesis 
techniques become more advanced, there can be interplay between more than two different 
physico-chemical properties on cellular interactions. A recent study has identified synergy 
between physical (shape), biological cue (antibody display) and route (cellular hitchhiking) 
for delivery to the lung endothelium133. It is thus crucial to be able to interrogate the role 
of properties size, shape, stiffness and chemistry independently in cellular interactions. 
To understand specific and combined role of particle properties in tuning cellular 
interactions, each physico-chemical property (size, shape, stiffness, chemistry) needs to be 
tuned without affecting the others. This is a major drawback with current particulate 
fabrication techniques, including LbL. Moreover, as particle fabrication techniques 
advance to meet the growing need to develop complex particles for enhancing therapeutic 
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delivery, identification of the inter-dependence between multiple physical properties on 
cellular interactions is critical. Additionally, with the current LbL engineered particles one 
is restricted to choose from the size or shape combinations that are readily available. These 
limitations need to be addressed to endow polyelectrolyte capsule particles with 
controllable properties that can aide in tuning cellular interactions. 
For the systematic fabrication of capsules using LbL, soft templates are attractive 
since independent manipulation of size and shape is possible32. Thus using soft templates 
could greatly increase the applicability of LbL to diverse shapes. However, capsules made 
using these templates suffer from severe aggregation issues during the centrifugation 
process and have incomplete template removal issues. Therefore, developing a LbL 
technique that addresses the issues with soft-template based capsule fabrication would have 
the ability to achieve independent control over particle properties- size and shape. The 
choice of the polyelectrolyte in combination with crosslinking chemistry during the LbL 
process can enable independent tuning of capsule stiffness. Thus, a modified LbL process 
on soft templates, is a promising solution to fabricate capsules with control over size, shape 
and stiffness that enable systematic investigation of the influence of physicochemical 
properties on cellular interactions. Further, such tunable particles will enable understanding 
the role of properties in influencing interactions when combined together. Additionally, it 
is crucial to understand the role of properties in affecting macrophage functions like 
cytokine production. 
The objectives of this thesis are: (1) development of an LbL technique applicable to 
soft templates that enables independent control over the physical properties of size, shape 
and stiffness while keeping surface chemistry constant, (2) understand the interplay 
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between these physical properties in tuning macrophage interactions (3) application of the 
LbL technique to control surface chemistry for reduction of macrophage interactions (4) 
understand the role of geometric presentation of varying ligands through manipulation of 
particle shape on macrophage function. 
1.9 Thesis Overview 
To achieve these objectives a modified LbL technique was developed in Chapter 2 
that is applicable to soft templates and overcomes aggregation issues common to soft 
template based LbL. In Chapter 3 this technique is adapted to enable independent control 
over each of the physical properties size, shape and stiffness while retaining the same 
surface chemistry. These engineered capsules are also employed in this chapter to 
investigate the role of the physical properties and interplay between them in macrophage 
interactions. In chapter 4, a modified LbL technique is presented that applies a zwitterionic 
polymer to impart stealth surface chemistry to particles for reduction of biological 
interactions. Chapter 5 combines active surface chemistries with particle shape and 
assesses their effect on macrophage interactions and inflammatory response. Finally, the 
work is summarized and an outlook is provided in Chapter 6.  
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CHAPTER 2. FABRICATION OF CAPSULES THROUGH 
MODIFIED LAYER BY LAYER TECHNIQUE 
 Particles are actively being used in biological applications such as drug delivery, 
vaccination to improve specificity or efficacy of drugs134. However, advances in the field 
have suggested that it is first critical to understand the role of physicochemical properties 
such as size7,41,52, shape34,35,135, surface chemistry6,136,137 and stiffness55,58,59 of the particles 
to achieve this. Hence tuning these properties to control biological behavior of particles is 
an active area of research. Polyelectrolyte capsules are a promising class of particles that 
have the ability to be tuned in each of these properties134. However, the major drawback 
with the current systems is their inability to tune these properties while keeping others 
constant.  
  To meet this challenge, we have fabricated novel polyelectrolyte capsules whose 
parameters size, shape can be independently controlled. In this chapter, these materials 
have been fabricated by combining soft organic templates created by the particle stretching 
method and a modified layer by layer (LBL) deposition process. The successful fabrication 
of these capsules is attributed to the weak hydrogen bonding and loose structure imparted 
to the capsules by this modified LbL method. In addition, the applicability of this method 
to generate diverse nano-scaled capsules is also highlighted. 
2.1 Experimental section 
2.1.1 Particle Preparation 
 Polystyrene (PS) particles were obtained from Polysciences. The shaped particle 
were fabricated based on a previously reported method32. In brief, 1 mL of 2.6 wt% PS 
spheres was combined with 9 mL polyvinyl alcohol (hydrolyzed degree 99+%, Mw 85-
 30 
124 kDa, 1 mg mL-1, Sigma Aldrich) and dried in air to form a film with thickness of ~75 
Pm. The air-dried film was stretched in a hot oil bath maintained at 120°C. The stretch 
ratio was defined as the ratio of the length of stretched film to the length of the original 
film.  The stretched film was allowed to cool to room temperature and dissolved in 70/30 
v/v% water-isopropyl alcohol (BDH) at 65°C. The particles were centrifuged for 15 min at 
1k, 10k, and 30k rcf for 3 Pm, 500 nm and 200 nm particles, respectively using Allegra X-
15R Centrifuge (Beckman Coulter). The particles were washed in this water-isopropyl 
alcohol 4 times and the particles were finally dispersed into 80% ethanol (Sigma- Aldrich). 
2.1.2 Synthesis of PAA-FITC  
 Fluorescein isothiocyanate (FITC, Sigma Aldrich) was dissolved in dimethyl 
sulfoxide (DMSO, BDH) to 0.1 M. Polyacrylic acid (PAA, Mw ~100 kDa, Alfa Aesar) 
was dissolved in 80% DMSO to 0.1 M. 12 mg N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide (EDC, Thermo Scientific) was added to 3 mL PAA solution, 8 mg ) N-
hydroxysuccinimide (NHS, Sigma-Aldrich) was added after 10 min to this mixture. The 
reaction was allowed to proceed for 5 minutes after which 20 PL FITC solution was added. 
The reaction was carried out overnight after which the solution was dialyzed against 80% 
ethanol for 24 hours. The entire reaction and dialysis process was protected from light.  
2.1.3 LbL Assembly on PS Particles and Capsule Fabrication  
Layer-by-layer (LbL) on spherical and shaped particles was carried out in ethanol. 
Polyelectrolytes polyvinylpyrrolidone (PVP, Mw ~ 55 kDa, Alfa Aesar), branched 
polyethylenimine (PEI, Mw ~ 120 kDa, Alfa Aesar) and PAA were chosen to facilitate 
LbL on particles. The stock solutions of bPEI (5 mg/mL), PVP (5 mg/mL) and PAA (5 
mg/mL) were prepared in 80% ethanol.  
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100 µL of a 2.6 wt% suspension of PS particles were dispersed in 4 mL 80% ethanol. To 
this suspension 1 mL of the first adsorbing solution (bPEI) was added, and adsorption was 
allowed to proceed for 10 min with sonication. Then particles were collected by 
centrifugation for 10 min (1k, 5k, and 10k rcf for 3 Pm, 500 nm and 200 nm particles 
respectively). The supernatant was removed and the particles were washed two times by 
resuspending in 80% ethanol. Particles were further functionalized with other 
polyelectrolytes PAA, PAA-FITC, or PVPON using the procedure mentioned above with 
the same washing protocol. The final multilayer obtained on the particle is as follows: 
PS/PEI/(PAA/PVPON)4.5.  
 For capsule fabrication, the layered particles were dissolved in 4 mL of 
tetrahydrofuran (THF, Alfa Aesar) for 2 min. The particles were centrifuged for 25 min 
(1k, 5k, and 8k rcf for 3 Pm, 500 nm and 200 nm particles respectively). The supernatant 
was removed and the pellet was rinsed with THF 2 times, using 200 PL THF each time. 
Finally, the capsules were dispersed in water (500 PL). 
2.1.4 FTIR Characterization of LbL assembly  
 PAA and PVPON samples were prepared from the stock solutions, and were 
dialyzed against water (pH ~ 3.0) overnight for FTIR. The solutions were freeze dried prior 
to testing. The PVPON/PAA films were prepared on glass substrate from the same 
conditions mentioned in the previous section by the typical LBL process. The formed 
multilayers were scratched off by a razor and dried under vacuum, PS particles, layered PS 
particles, and capsules were freeze dried (Millrock Bench Top Freeze Dryer) after 
fabrication. In order to avoid any interference from water, all the samples (particles or 
films) were kept in vacuum for at least 3 days before grinding with KBr for FTIR 
measurements. 
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2.1.5 Particle characterization  
 Particle size distribution was measured by dynamic light scattering using a 
Zetasizer Nano ZS90 (Malvern Instruments Ltd.). The samples were measured in water at 
25°C and a scattering angle of 90°. Average particle size was calculated as the arithmetic 
mean of the distribution of at least three batches of particles. Zeta potential was determined 
by measuring the electrophoretic mobility of nanoparticles in water using the same 
instrument. FTIR spectra were obtained on a Bruker Vertex 70 FTIR spectrometer 
equipped with a DTGS detector. Transmission electron microscopy (TEM) was carried out 
on a JEM-2010 microscope operating at 100.0 kV. A Zeiss Axio Observer Inverted 
Microscope Z1 was used for fluorescence microscopy images. Scanning electron 
microscopy (SEM) images were taken on a JEOL JSM 5600LV scanning electron 
microscope operating at 15 kV.  
2.2 Results and Discussion 
2.2.1 Modified LbL for the fabrication of tunable capsules 
Soft templates like polystyrene (PS), polylactic-co-glycolic acid (PLGA) offer the 
advantage of fabrication of particles of varying sizes and shapes with independent control 
unlike hard templates like calcium carbonate32,138,139. However, the major challenge in 
using soft templates to fabricate capsules is the aggregation of particles during LbL process 
when carried out in water, based on traditional electrostatic interactions between the 
polyelectrolytes. These particles are susceptible to aggregation during the collection step 
of this process due to the comparable densities of the soft templates and water. In addition, 
realizing capsule fabrication on the nano-scale based on electrostatic interactions is 
challenging due to increased surface energy for nano-sized particles.  
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In order to circumvent these issues, we explored the use of organic solvents. 
Mixtures of organic solvents with water has a lower dielectric constant than water 
effectively screening electrostatic interactions and thus enabling favorable multilayer 
interactions140. In addition, switching the solvent to organic solvent-mixture like 80% 
ethanol reduces the centrifugal force required to collect particles and thereby potentially 
avoiding aggregation. More importantly, the decreased surface energy of particles in 
ethanol, as compared to water, ensures re-dispersion of the particle pellet under slight 
sonication or shaking.  
Polyacrylic acid (PAA) and polyvinylpyrrolidone (PVPON) were chosen as 
building blocks for capsule fabrication because of their good solubility in ethanol.  
Previously, hydrogen bonding based LbL has been executed in water or methanol between 
the proton donor of the COOH in PAA and the proton acceptor of C=O in PVPON140–142. 
However, the formation of hydrogen bonding between PAA and PVPON in ethanol 
considering its low polarity than water or methanol is unknown. 
 Hydrogen-bonding based LbL was executed in ethanol on carboxylated PS particles 
(diameter 3 Pm and aspect ratio 1, PS3Pm-r1). The buildup of the layers was monitored by  
zeta-potential, which changed as a function of the charge of the end group in the depositing 
polyelectrolyte (Figure 2.1a). PEI was coated first on the PS particle to impart a high charge 
density critical for subsequent layer deposition. 53 The size dependence of the particle with 
each depositing layer was monitored. No size dependence on the number of depositing 
layers was observed confirming good dispersion and no aggregation during the LbL 




Figure 2.1. Zeta-potential and size characterization of layered particles. (a) The 
dependence of zeta-potential of PS3µm-r0/PEI/(PAA/PVPON)4.5 on the number of 
layers. (b) Particle size dependence on the number of polyelectrolyte layers as 
measured by dynamic light scattering. The values reported are the average of at least 
3 batches and the error bars indicate standard deviation. 
 The final multilayered particles (PS3Pm-r1/PEI/(PAA/PVPON)4.5) were incubated in 
THF to remove the PS core and form hollow capsules.  The size of the capsules was 
measured, as shown in is similar to the layered particles but slightly larger, due to the 
swelling of the capsule wall62. The formation of hydrogen bonds between PAA and 
PVPON in ethanol was confirmed by Fourier transform infrared (FTIR) 
spectroscopy142,143. As shown in Figure 2.2b the peak centered at 1666 cm-1 in the top 
spectrum is assigned to the vibration of the carbonyl groups in PVPON, while the peak 
centered at 1714 cm-1 in the middle spectrum is attributed to the vibration of the carbonyl 
function of PAA carboxylic acid groups in the associated state. Compared to the spectra of 
pure polyelectrolytes, the carbonyl vibration of PAA in the film shifted to a higher 
wavelength number, 1728 cm-1, revealing that the carbonyl group is in a less-associated 
state than in pure PAA. Meanwhile the carbonyl vibration of PVPON in the film shifted 
lower, with the center at 1652 cm-1. These data demonstrate that hydrogen bonding between 
PAA and PVPON is the driving force for the film growth140,142. 
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Figure 2.2. Size distribution and FTIR characterization of capsules. (a) Size 
distributions of layered particles (PS3Pm-r1/PEI/(PAA/PVPON)4.5, black line), and 
capsules after removal of the PS template (PEI/(PAA/PVPON)4.5, red line), (b) FTIR 
spectra of pure PVPON (top, black), PAA (middle, red) and LBL PAA/PVPON films 
(bottom, blue) prepared in ethanol.  
 Fluorescent capsules were also prepared using the same technique by 
functionalizing PAA with FITC. Fluorescent microscopy images indicate the ability of the 
capsules to retain the template shape, confirm their dispersability and the absence of any 
aggregation (Figure 2.3a). Conversely, serious aggregation was observed when the same 
particles were fabricated in water (Figure 2.3b). We hypothesize that good dispersion was 
mainly due to the lower surface energy and lower density of ethanol. The lower density 
reduced the centrifugal force from 6000g in water to 1000g in ethanol enabling control of 
aggregation during the LbL process. 
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Figure 2.3. Capsule images after LbL process. (a) Fluorescent image of the capsules 
PEI/(PAA-F/PVPON)4.5 fabricated with ethanol as solvent. Scale bar is 5 Pm. (b) 
Optical image of the capsules, PEI/(PAA-F/PVPON)4.5 fabricated with water as 
solvent. Scale bar is 5 Pm. 
2.2.2 Altering solvent composition enables formation of capsules 
For the intact formation of capsules, it is critical to ensure complete removal of the 
core. Previously, removal of the polystyrene core from LbL systems based on electrostatic 
interactions suffered from long treatment times and low yield of good quality capsules61,72. 
However, in our system only a two-minute incubation led to complete removal of the 
polystyrene core. 
We believe that our choice of the solvent enabled quick removal of the template. 
The solvent composition is considered as an important parameter in tuning the 
polyelectrolyte interactions140,143,144. The combination of organic solvent and water lowers 
the dielectric constant compared to water thereby enabling effective screening of 
electrostatic interactions. It has been shown that presence of organic solvents causes a great 
deal of structural changes in the polyelectrolyte multilayer shells leading to permeability 
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changes. In our case, the ethanol-water solution caused structural changes in the 
polyelectrolyte and the weak hydrogen bonding between the multilayers contributed to a 
loosely bound multilayer. This loose structure enabled removal of the organic templates 
which comprises swelling of the template, then dissolution and diffusion out of the capsule.   
 Removal of the PS template was verified by FTIR in Figure 2.4a. The top spectrum 
was obtained from the original PS particles, where the peaks centered at 758 cm-1 and 698 
cm-1 are assigned to the out-of-plane hydrogen deformation of a mono-substituted phenyl 
group and the out-of-plane ring deformation for a mono-substituted phenyl group, denoted 
as characteristic peaks of PS145. After assembly of PEI/(PAA/PVPON)4.5 layers on PS 
particles (middle spectrum), the peaks between 1550 cm-1 to 1850 cm-1 widen, 
demonstrating the successful deposition of the layers without losing the characteristic PS 
signals. After incubation in THF to produce capsules (bottom spectrum), the characteristic 
PS peaks disappear while the peaks at 1728 and 1652 cm-1 from the carbonyl vibration of 
PAA and PVPON remain. TEM images of the capsules confirmed the absence of core as 
seen in Figure 2.4b. This indicates complete removal of PS template. 
 
Figure 2.4. PS Core dissolution confirmation by FTIR and TEM (a) FTIR spectra of 
the original PS3Pm-r1 particles (top, black), coated particles (PS3Pm-
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r1/PEI/(PAA/PVPON)4.5, middle, red), and capsules obtained by incubating PS3Pm-
r1/PEI/(PAA/PVPON)4.5 in THF for 2 min (bottom, blue). (b) TEM image of the 
capsules. Scale bar is 2 Pm.  
 
 The role of weak hydrogen bonding in supporting the loose structure of the capsules 
was tested by the incubation of capsules in THF for long period of 40 minutes. This led to 
the breakage of capsules (Figure 2.5a-b) unlike the capsules formed by electrostatic 
interactions which can endure at least several hours of THF treatment without breaking146. 
The loose structure theory was also tested by making crosslinked capsules. As a control, 
PAA in the layered particles was crosslinked by EDC/NHS in the presence of 
hexamethylenediamine. After crosslinking the template could not be removed because of 
the limited space in the compacted network structure of the crosslinked layers (Figure 2.5c-
d). Increasing the incubation time (2 days) or the incubation temperature (37°C) in THF 
did not help core removal. These results illustrate that the loose structure of the layers was 
critical for core removal. 
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Figure 2.5. Transmission electron microscopy (TEM) images of layered particles 
PS3Pm-r1/PEI/(PAA/PVPON)4.5 (a) before and after (b) 40 min, (c) overnight THF 
treatment to remove the core, and (d) incubated in THF for 2 days after crosslinking 
by EDC/NHS in the presence of hexamethylene diamine Scale bar 2µm. 
2.2.3 Independent control over size and shape of capsules 
 The ability of the modified LbL technique to exercise independent control over size 
and shape was tested was by stretching PS particles into different shapes. The same PS 
particles were used as the starting material thereby conserving volume. The layered 
template was then treated with THF to form capsules. The capsules were monitored by 
fluorescence microscopy and are shown to retain the template shape and be well dispersed 
(Figure 2.6a). By TEM, the capsules were observed to be intact without broken or damaged 
walls (Figure 2.6b). We also tested the applicability of the method to fabricate capsules of 
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the same shape and size but higher stretch ratio, 3, PS3Pm-r3 particles. Stretching causes 
significant changes to the shape of the particles, affecting the charge distribution on the 
surface which is critical to LBL layer deposition. Another concern is the ability to maintain 
the shapes of capsules after the template dissolved. The layered capsules 
PEI/(PAA/PVPON)4.5 layers were monitored after core removal using fluorescence 
microscopy (Figure 2.6c) and TEM (Figure 2.6d). This confirms that the template shapes 
were preserved and well dispersed, indicating the capsule walls were stiff enough to 
support the shape without deformation. 
 
Figure 2.6. Fluorescent images of PEI/(PAA-F/PVPON)4.5 shaped capsules. (a) PS3Pm-
r2 and (c) PS3Pm-r3 template particles. TEM images of PEI/(PAA-F/PVPON)4.5 
capsules, fabricated from (b) PS3Pm-r2 and (d) PS3Pm-r3 template particles. Scale bars 
are 5 Pm for (a) and (c), and 2 Pm for (b) and (d). 
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2.2.4 Fabrication of nanocapsules 
 The fabrication of nanocapsules is challenging due to their higher surface energy 
making it difficult for re-dispersion and are prone to high aggregation during 
centrifugation. The applicability of this technique was tested to templates of size 500 nm 
with stretch ratio 3 (PS500nm-r3) and 200 nm with stretch ratio 2 (PS200nm-r2). The size 
distributions were assessed by DLS. As shown in Figure 2.7a-b, a single population of 
layered particles was observed, with size distributions centered at radii of 240 nm and 120 
nm for PS500nm-r3 and PS200nm-r2, respectively. This is coincident with the size of original 
particles, though DLS cannot accurately measure the size of anisotropic particles. The size 
distribution of the capsules after core removal as shown in Figure 2.7a-b, the peak of the 
size distribution shifted larger, as with spherical templates, but remained a single 
population. These data illustrate good dispersion of the shaped nanocapsules. As observed 





Figure 2.7. Size distributions of particles and TEM images of capsules. (a) PS500nm-r3 
layered particles (black line) and capsules (red line), (b) PS200nm-r2 particles layered 
particles (black line) and capsules (red line). TEM images of PEI/(PAA-F/PVPON)4.5 
capsules, (c) PS500nm-r3 and (d) PS200nm-r2 particles. Scale bars are 1 Pm and 500 nm for 
(c) and (d) respectively. 
2.3 Summary 
In summary, we developed a method for fabrication of polyelectrolyte capsules with 
constant surface chemistry and independently controlled size and shape by combining 
particle stretching with soft template LBL. Capsule aspect ratio can be tuned by template 
stretching independent of the size (volume), and the size (volume) of capsules can be tuned 
by selection of the initial sphere size without altering the shape and aspect ratio of the 
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capsule.  Switching the solvent, enabled multilayer formation on particles through 
hydrogen bonding and facilitating a loose structure of the shell when treated with 
tetrahydrofuran for capsule fabrication. This method is highly versatile for the production 
of capsules with a wide range of sizes and shapes. This method will enable the optimization 
of physical properties of particles for drug-delivery applications or to further elucidate the 
interaction of particles with cells. 
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CHAPTER 3. FABRICATION OF TUNABLE PARTICLES AND 
ELUCIDATION OF COMBINATORIAL EFFECTS OF 
PHYSICAL PROPERTIES ON MACROPHAGE UPTAKE  
 Polymeric micro and nanoparticles are useful carriers for drugs and vaccines147,148. 
However, their fate in the system is dependent upon their interaction with macrophages. 
Particle properties such as size6,7,149, surface chemistry6,40,150–152, shape37,75,153, and 
elasticity53–56,58,59,154 have been identified as crucial in tuning interaction of particles with 
these cells. Most of these studies above have elucidated the effect of either one or two 
physical properties on cellular interactions. However, as particle synthesis techniques 
become more advanced, there can be interplay between more than two different physico-
chemical properties on cellular interactions. A recent study has identified synergy between 
physical (shape), biological cue (antibody display) and route (cellular hitchhiking) for 
delivery to the lung endothelium133. It is thus crucial to be able to fabricate tunable particles 
with independent control over properties to understand the interplay between properties on 
cellular interactions.  
 In this chapter, we have adapted the template based layer-by-layer assembly 
process from the previous chapter to fabricate tunable particles whose size, shape, 
elasticity, and ligand immobilization can be controlled independently while retaining the 
same surface chemistry. We systematically investigated the combined contributions of 
these properties on cellular interactions during Fc- mediated phagocytosis, revealing 
complex interplay between the properties. Particles varying in multiple physical properties 
exhibit very different trends during interactions with macrophages. We demonstrate the 
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interplay between size, shape and stiffness in tuning the specificity of Fc ligand 
functionalized particle interactions with macrophages during phagocytosis. 
3.1 Experimental methods  
3.1.1 Particles and fabrication of rod shaped particles  
The geometry of the particle has been recognized as an important design parameter 
for phagocytic interactions. In this work, spherical or rod shaped geometries were used to 
illustrate the combinatorial effects on such interactions.  Spherical carboxyl functionalized 
polystyrene (PS) particles (3µm, 6µm) were used without any modifications from the 
manufacturer (Polysciences). Rod shaped particles were fabricated using our previously 
reported method. Briefly, 1 ml of 2.6 wt% spheres was suspended in polyvinyl alcohol 
(PVA, hydrolyzed degree 99+%, Mw = 85-124 kDa, Sigma Aldrich) solution (0.1 g/ml) 
and the solution was dried to yield a film of thickness of ~70 µm. The film was stretched 
in a hot oil bath at 120˚C to an aspect ratio of 2.5. The film was cooled to room temperature 
and the particles were extracted from the film by heating the film in 30% isopropyl alcohol-
water (BDH) solution maintained at 65˚C. The particles were then centrifuged at 2500 g 
using Allegra X-15R Centrifuge (Beckman Coulter) for 15 minutes. This process of 
washing was repeated 6 times and the particles were dispersed in 80% ethanol (Sigma-
Aldrich). 
3.1.2 Functionalization of polyacrylic acid with fluorescein isothiocyanate and thiol 
molecules  
Fluorescein isothiocyanate (FITC) was first modified to enable its conjugation to 
polyacrylic acid (PAA).  FITC was dissolved in dimethyl sulfoxide (DMSO, BDH) to 0.2 
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M. N-(3-dimethylaminopropyl)-N-ethylcarbodiimide (EDC, Sigma-Aldrich) and N-
hydroxysuccinimide (NHS, Sigma-Aldrich) were added to the mixture at a molar ratio of 
1.4:1.2:1 (EDC:NHS:FITC). The reaction was carried out for 10 minutes and 1,6 diamine 
hexane (Alfa Aesar) was added to the mixture at a molar ratio of 0.9:1 (1,6 diamine 
hexane:FITC). The reaction was protected from light and carried out overnight. The 
solution was centrifuged to remove any precipitates. 
The functionalization of PAA was carried out as follows. PAA (36 mg/ml, Alfa 
Aesar) was dissolved in 50% DMSO. EDC (43 mg) was added to the mixture followed by 
NHS (26 mg) and allowed to react for 10 minutes. pyridine dithioethylamine hydrochloride 
(44 mg/ml, Chem-Impex International Inc.) and modified FITC as described above (0.2 M) 
were added simultaneously to the above mixture and the reaction was allowed to proceed 
overnight. The resulting mixture was then dialyzed against 50% ethanol with 0.025 v/v% 
β- mercaptoethanol (Sigma-Aldrich) overnight. The functionalized polymer was finally 
reduced with dithiothreitol (1 M, G-Biosciences) for at least three hours. PAA 
functionalized with FITC and thiol will be referred to as PAAm in this chapter. For the 
non–fluorescent version of PAAm with thiol, the same protocol was used without FITC. 
3.1.3 Layer-by-layer assembly on particles and capsule fabrication  
Layer-by-layer (LbL) on spherical and rod shaped particles was carried out in 
ethanol. Polyelectrolytes polyvinylpyrrolidone (PVP, Mw ~ 55 kDa, Alfa Aesar), branched 
polyethylenimine (PEI, Mw ~ 120 kDa, Alfa Aesar) and PAA were chosen to facilitate 
LbL on particles. The stock solutions of PEI (5 mg/mL), PVP (5 mg/mL) and PAA (5 
mg/mL) were prepared in 80% ethanol. 
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150 µl of 2.6 wt% suspension of PS particles were dispersed in 4 ml of 80% ethanol. 
To this, 1 ml of each adsorbing polyelectrolyte layer from the stock solution was added. 
The suspension was sonicated for 10 minutes and centrifuged at 1000 g for 10 minutes. 
The polyelectrolyte adsorbed particles were then washed in 80% ethanol through 
sonication and collected through centrifugation. In this way 
(PVP/PAA)2PEI(PAAm/PVP)2PAA coated particles were obtained. Particles were 
crosslinked using 1 mM chloramine trihydrate (CaT, Acros Organics) solution for 2 
minutes. Polyelectrolyte coated particles were suspended in 750 µl tetrahydrofuran (THF, 
Alfa Aesar) for 2 minutes to remove the PS and form capsules. The capsules were then 
centrifuged at 1000 g for 2 min and this process was repeated once. The capsules or coated 
particles retaining their core (referred to as core-shell particles) were suspended in 
phosphate buffered saline (PBS, 10 mM NaH2PO4, 137 mM NaCl, 2.7 mM KCl, 2mM 
KH2PO4; pH 7.4) for cell studies. 
3.1.4 IgG functionalization of particles  
The particles (core-shell or capsule) were functionalized with IgG by coating first 
with bovine serum albumin (BSA, Fischer Scientific) using 10 times excess of the surface 
monolayer saturation as calculated from the manufacturer’s protocol. The particles were 
incubated with BSA (1 mg/ml) in PBS for two hours, washed three times in PBS and 
collected by centrifugation at 1000 g for 2 minutes. BSA coated particles were incubated 
for one hour with rabbit anti-BSA IgG antibody (ThermoFisher Scientific) at a mass ratio 
of 1:1 (BSA: IgG). The IgG functionalized particles were washed three times with PBS. 
To confirm the presence of IgG, particles were incubated for 30 minutes with FITC goat-
anti-rabbit IgG (BD Life Sciences) and washed with PBS three times. The washed particles 
 48 
were assessed by flow cytometry (Accuri C6, Beckton Dickenson Biosciences). 
3.1.5 Particle imaging  
 Fluorescent images of particles were taken using a Zeiss Axio Observer Z1 inverted 
microscope. The ability of spherical capsules to conform to a circle was measured using 
the circularity function in ImageJ software. Transmission electron microscopy was carried 
out using JEOL 100CX-II microscope operating at 100.0 kV. Particles were dropped on a 
Cu grid 400 mesh (Electron Microscopy Sciences) and allowed to settle for 10 minutes. 
Any excess solution was wiped off and the grid was left to dry overnight before imaging. 
3.1.6 Stability of capsules in media  
The stability of capsules was tested by incubating 106 particles in DMEM media 
supplemented with 10% FBS for 48 hrs. The particles were gated by their forward and side 
scatter and retained similar fluorescence. The particles were then counted at 0, 24, and 48 
hrs by flow cytometry. Experiments were performed in triplicate and data represented as 
the mean +/- standard deviation. 
3.1.7 Cytotoxicity assay  
The cytotoxicity of the capsules was evaluated using lactate dehydrogenase (LDH) 
assay. J774 cells, 10,000 in number were plated in triplicate in a 96 well plate. Particles at 
the ratio of 10:1 particles:cell or 10 µl of sterile water were added to the wells and incubated 
for 24 hrs. Controls for maximum LDH activity were also run according to the 
manufacturer’s instructions (Pierce LDH Cytotoxicity Assay, Thermo Scientific). 50 µl of 
each sample condition was transferred to a 96 well plate. 50 µl of reaction mixture was 
added to each well and mixed. The reaction was protected from light for 30 minutes and 
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50 µl of stop solution was added to each well. The absorbance values were measured at 
490nm and 680 nm using Biotek Synergy H4 Multimode plate reader (Biotek Instruments 
Inc) and reported as % cytotoxicity according to the manufacturer’s instructions. 
3.1.8 Size and zeta-potential of particles  
The size of the capsules was determined by dispersing 105 capsules stored in PBS 
for 24 hours into a counting chamber glass slide and their size distribution was determined 
using a Cellometer Auto M10 Counter (Nexcelom Biosciences). Zeta-potential was 
determined by measuring the electrophoretic mobility of particles in 10 mM NaCl using a 
Zetasizer Nano ZS90 (Malvern Instruments Ltd.). Non- fluorescent PAAm was used to 
determine the zeta-potential of particles. 
3.1.9 Thiol quantification  
The thiol content was determined from Ellman’s test (Uptima). Briefly, 50 µl of 
(DTNB solution- 2 mM Dithio-bis-(2-nitrobenzoic acid), 50 mM sodium acetate), 100 µl 
of Tris solution (1 M), and 840 µl water were mixed. To this working solution either 10 µl 
of PAAm sample or standard was added. The solution was mixed well and incubated at 
room temperature for 5 minutes. The absorbance values were recorded at 412 nm. Based 
on the calibration curve, the thiol content was computed. The thiol content was estimated 
for three different batches of PAAm. 
3.1.10 Cell Culture 
J774 macrophages (American Type Culture Collection (ATCC)) were grown in 
Dulbecco’s Modified Eagle’s Medium (DMEM) (ATCC) at 37˚C in a humidified 
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atmosphere containing 5% CO2. The media was supplemented with 10% fetal bovine 
serum (Seradigm) and 1% penicillin/streptomycin (Amresco). The cells were used between 
passages 4 and 15. 
3.1.11 Particle association with cell 
The particle association with cells was assessed by flow cytometry and confocal 
microscopy. For flow cytometry, 105 J774 cells per well were plated in a 24 well plate 
overnight. Particles were added to the cells in supplemented media at 10 particles/cell. The 
cells were incubated with particles for two hours. The cells were then washed with cold 
PBS three times and scraped from wells. Duplicate samples were centrifuged at 3000 g for 
3 minutes, treated with 200 µl trypan blue, and immediately interrogated on the flow 
cytometer. Control samples were run at 4˚C and corresponding duplicate samples were 
treated with trypan blue to determine the effectiveness of quenching attached particles. Cell 
populations were gated and threshold fluorescence was established based on the auto-
fluorescence of J774. Cell events beyond this threshold were reported as particle positive 
cells. The phagocytic assay was repeated three times using three different batches of 
prepared particles. Particle quenching by trypan blue was confirmed by incubating 105 
fluorescent particles in 200 µl of trypan blue and interrogating immediately on a flow 
cytometer. 
For confocal microscopy, 104 cells were plated in a Lab-Tek II chamber slide 
(Thermo Fisher Scientific) and allowed to adhere at least 6 hours. Particles were added to 
cells at 10 particles/cell and incubated with cells for one hour. The cells were washed with 
cold PBS twice and fixed with 3.7% formaldehyde for 15 minutes at room temperature. 
 51 
The cells were then washed with PBS once quickly and two times for 5 minutes. 1% 
Triton–X 100 in PBS was used to permeabilize cells for 15 minutes at room temperature. 
The cells were washed three times with PBS after permeabilization. Phalloidin-rhodamine 
(Sigma Aldrich) was used to stain the actin at a volume dilution of 1:500 for 15 minutes at 
room temperature. The cells were washed three times before imaging using a Zeiss LSM 
700-405 Confocal Microscope (Carl Zeiss Microscopy, LLC). 
3.2 Results and discussion 
3.2.1 Fabrication and characterization of tunable particles  
With the aim of understanding the combinatorial effect of physical properties on the 
process of phagocytosis by macrophages, tunable particles in the form of core-shells or 
capsules were prepared through a self-assembly process called layer-by-layer. Polyacrylic 
acid (PAA) and poly(vinylpyrrolidone) (PVPON) and polyethylenimine (PEI) were chosen 
as the precursors for this process due to their solubility in ethanol. The choice of the solvent 
has been shown to be critical to prevent aggregation of particles during layer-by-layer 
(LbL) on soft templates155. Despite the low polarity of ethanol, hydrogen bonding between 
PVPON and PAA is strong enough to sustain LbL on polystyrene (PS) particles. PEI is 
used as a middle layer to impart high charge density for subsequent layer deposition. Zeta 
potential was used to monitor the progress of LbL on the particles. The zeta potential values 
changed as a function of the charge of the end group in the depositing polyelectrolyte 
(Figure 3.1). Depending on the choice of polyelectrolyte, the interactions of the hydrogen-
bonded layers are susceptible to disintegration at physiological pH 156,157. At a pH above 
the pKa of PAA, 4.2158, its ionization disrupts hydrogen bonding, rendering capsules 
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unstable. In such cases, crosslinking of hydrogen bonded layers through amide or thiol 
chemistry is commonly used to endow stability to capsules for biological applications64. 
Hence, we functionalized PAA with thiols in the presence of EDC and NHS yielding PAA 
with 10 mol% of thiol containing units. This polyelectrolyte was further modified with 
FITC (PAAm) to fluorescently label the particles enabling monitoring upon interaction 
with macrophages. Functionalization of PAA did not affect the build-up of layers, as seen 
from the zeta potential in Figure 3.1. 
 
Figure 3.1. Zetapotential of particles during LbL process. Data represented as mean 
+/- standard deviation (n = 3). 
These layers were crosslinked with chloramine trihydrate (CaT) which has been 
shown to oxidize thiols controllably157. The layered templates 
(PVP/PAA)2PEI(PAAm/PVP)2PAA were incubated in THF to remove the PS core. The 
core removal was further confirmed by TEM as seen in Figure 3.2. The removal of the core 
was shown to result in reduction of the elasticity of tannic acid/ polyvinylpyrrolidone 
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capsules when compared to their core-shell54,72. Hydrogen bonding between the layers of 
capsules was also shown to substantially reduce elasticity in comparison to traditional LbL 
capsules based on electrostatic interaction72. 
 
Figure 3.2. TEM images of capsules A) 3µm sphere, B) rod (scale bars 2 µm). 
Figure 3.3 shows fluorescence images of the particles. The capsules retain the morphology 
of the template and 6 µm capsules appear more deformable than 3 µm capsules. Rod shaped 
core-shell particles and corresponding capsules were also made using the same LbL 
technique on rod-shaped templates (12 +/- 0.2 µm in length and 2.5 +/- 0.23 µm in width) 
stretched from 3 µm polystyrene spheres, thereby conserving particle volume. The rod 
capsules retain the shape of the template as seen in Figure 3.3c-d. 
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Figure 3.3. Fluorescence images of particles. A) 3 µm spherical capsules (scale bar 5 
µm), B) 6 µm spherical capsules (scale bar 10 µm), C) rod shaped core-shell particles 
(scale bar 10 µm), D) rod shaped capsules (scale bar 5 µm). 
The particles were also characterized for their size, stability and cytotoxicity to 
macrophages. The size distribution of the hollow spherical capsules (3 µm and 6 µm) in 
PBS was found to be similar to that of corresponding core-shell particles as evident in 
Figure 3.4A-B. This confirms the conservation of size and the dispersability of the 
capsules. Through this layer-by-layer technique we fabricated core-shell particles (3 µm 
sphere, 6µm sphere, rod) and corresponding capsules (3 µm sphere, 6µm sphere, rod) of 
the same surface chemistry yet varying in size, shape and elasticity. The stability of 
capsules was tested in biologically relevant media, DMEM supplemented with 10% serum 
as shown in Figure 3.4C, and they were found to be stable for at least two days. The 
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particles were determined to be non-cytotoxic to macrophages after incubation for 24 hrs 
in Figure 3.4D. 
Isolating the effects of physicochemical properties on cellular interactions is 
critical to understand the roles that these properties can have when combined. Choice of 
particle size often depends on the in vivo application159. The advancement of techniques 
such as particle replication in non-wetting template (PRINT), stretching and liquefaction, 
step flash imprint lithography and self-assembly have enabled the fabrication of various 
non-spherical particles135. Stiffness of capsules can be altered by varying the number of 
layers, cross-linking, choice of material or maintaining/removing the core160. It is crucial 
to maintain similar size and shape during these processes while tuning stiffness. Our 
platform based on the choice of template particle size, method of stretching, and hollow 
preparation enables control over these properties and can help understand any interplay 




Figure 3.4. Characterization of particles. A) Size distribution of 3 µm core-shell and 
capsule particles measured in PBS, B) Size distribution of 6 µm core-shell and capsule 
particles measured in PBS, C) Stability of spherical 3 µm capsules in DMEM 
supplemented with 10% serum, D) Cytotoxicity of 3 µm core-shell and capsule 
particles to J774 cells following 24 hrs incubation. Positive control indicates a strongly 
cytotoxic agent provided by the manufacturer. 
3.2.2 Interaction of tunable particles with macrophages  
3.2.2.1 Opsonization of tunable particles  
When particles are introduced systemically or locally into the body they encounter 
macrophages5,161. Macrophages are capable of phagocytosing particles through varied 
mechanisms, though Fc receptor mediated is the most widely studied162. Hence, to promote 
specific particle interactions with macrophages, core-shell and capsule particles were 
opsonized with Immunoglobulin-G (IgG). To achieve proper orientation of IgG Fc domain 
to Fc receptors, the particles were first coated with BSA followed by incubation with anti-
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BSA IgG antibody. IgG functionalization of particles as shown in Figure 3.5 was confirmed 
by flow cytometry.  
Recently, the density of Fc-ligand functionalization on spherical particles of 
different sizes has been shown to affect overall phagocytosis by macrophages52. The 
influence of such biological cues was shown to be negligible for spheres of sizes beyond 3 
µm. Hence, for our 3µm and 6 µm spherical particles any effects of Fc-ligand density on 
phagocytosis would be negligible. For the case of rods, the influence of Fc density on 
shaped capsules and corresponding core-shells has been eliminated by equivalent antibody 
functionalization (Figure 3.5B). 
 
Figure 3.5. Opsonization of particles with anti-BSA IgG antibody and incubated with 
secondary antibody to confirm IgG presence. A) Spherical 3 µm core-shell and 
capsule particles after opsonization: core-shell (blue), capsule (green), and negative 
controls incubated with BSA and secondary antibody only, core- shell (red) and 
capsule (brown), Rod core-shell and capsule particles after opsonization: capsule 
(brown), core-shell (blue), negative control incubated with BSA and secondary 




3.2.2.2 Effect of trypan blue on attached and internalized particles  
The effect of various particle physico-chemical properties size, shape, surface 
chemistry and stiffness has been extensively studied to tune phagocytic interactions 
between macrophages and particles6,7,9,153. Attachment and internalization are the first two 
steps of the phagocytic process. To understand the independent effect of particle properties 
on internalization at 37˚C we used trypan blue quenching of FITC to differentiate between 
cells with membrane bound particles from cells that had completely internalized particles. 
Trypan blue quenched the fluorescence of particles as shown in Figure 3.6 by at least an 
order of magnitude. To confirm the applicability of this technique to differentiate between 
attached and internalized particles with cells, particles were incubated with macrophages 
at 4˚C, which prevents energy-dependent internalization processes including phagocytosis. 
As with free particles in solution, trypan blue also quenched the fluorescence of all the 
different types of particles attached to macrophages at 4˚C, establishing the ability to 
distinguish between attached and internalized particles at 37˚C (Figure 3.7). 
 
Figure 3.6. Trypan blue quenching of particles. A) 6 µm particle- core-shell (yellow), 
capsule (blue), core-shell quenched (brown), capsule quenched (black). B) 3 µm 
particle- core-shell (black), capsule (red), core- shell quenched (brown), capsule 
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quenched (blue). C) Rod shaped particle- core-shell (red), capsule (black), core-shell 





Figure 3.7. Trypan blue quenching of core-shell particles attached to J774 at 4 ˚C: no 
trypan blue treatment (red), trypan blue treated (blue). Traces were consistent across 
two independent replicates. 
3.2.2.3 Effect of tunable particles on phagocytic process  
The effect of IgG functionalized capsule or core-shell particles on total association 
(attached and internalized) and internalization by macrophages was evaluated after two-
hour incubation with cells at 37˚C. The dependence of total association and internalization 
by macrophages due to varied particle physical properties is summarized in Figure 3.8. 
There was no statistical difference between the total association of core-shell particles or 
capsules of any kind. 
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Despite similar total association for particles of varying physical properties – size, 
shape, and stiffness, the internalization trend is different when any of these physical 
properties is altered. However, from one-way ANOVA analysis it is unclear if there exists 
any interplay between physical properties. For example, it is not clear if the effect of size 
for a spherical particle on phagocytic interaction is the same across varying stiffness. 
Likewise, the effect of altering shape from sphere to a rod on such interactions across 
varying stiffness is also unknown. Even when particles being compared appear to have 
only 1 physical parameter varied between them, the physical parameters size, shape and 
stiffness are inherently related to each other. Therefore, two-way ANOVA was performed 




Figure 3.8. Percentage of J774 macrophages that associated with particles of varied 
physical properties, as measured by cell fluorescence: total association (black), 
internalized (gray). Data represented as mean +/- standard deviation (n = 3). 
3.2.2.4 Interplay between size and stiffness of spherical particles 
The interdependence between size and stiffness on internalization of spherical 
particles is shown in Figure 3.9A . The internalization enhancement seen with decreased 
size is greater for capsules than for stiffer core-shell particles. This could be due to 
differences in the sizes or differences in the stiffness of particles. Two-way ANOVA 
analysis, summarized in Figure 3.9B, determines that size (p=0.001) plays a dominant role 
over stiffness (p = 0.4568) for these spherical capsules in affecting internalization. There 
is no significant interaction between size and stiffness on influencing internalization by 
macrophages (p= 0.5058). In a recent study, measurement of single-event engulfment of 3 
µm silica spheres by RAW macrophages exhibited ~2.8 times slower engulfment time than 
1.85 µm spheres164.This could be attributed to the energetics associated with deformation 
of the macrophage membrane during internalization of particles. Larger spherical PS 
particles (3 µm) have been reported to be taken up more slowly compared to 1.5 µm sized 
particles, suggesting that higher energy requirement for membrane deformation of large 
particles could abate uptake165. In addition, modeling of flexible nanoparticle interactions 
with membranes has identified the relative size between the particle and the interacting cell 
as a parameter in dictating the ability of the cell to execute complete wrapping of the 
particle166. The energy required for wrapping relatively larger particles is higher, which 
suggests this is the reason for the dominant effect of size in internalization. 
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It has been established that stiffness is inversely proportional to the radius of a thin 
hollow spherical shell (Appendix A), so larger capsules exhibit reduced stiffness167. 
Analysis of fluorescent images of capsules in solution (such as those in Figure 3.3) revealed 
that 6 µm capsules have 67% conformation to a circular shape, suggesting that 6 µm 
capsules are less stiff than 3 µm capsules, which have 85% conformation. This is also 
evidenced from confocal microscopy images in Figure 3.10, where 6 µm capsules are 
deformed by the cell membrane while 3 µm capsules maintain their spherical shape. While 
these measurements ascertain the differences between these capsules qualitatively, 
obtaining quantitative measurements of spherical capsules has been challenging due to 
fouling of AFM tip with particles upon contact. To prevent this, two strategies were 
employed. Polyelectrolyte treated surfaces were used to ensure that the capsule was 
immobilized on the surface. The surface was treated with various polyelectrolytes like 
PVP, poly-L lysine and PEI to facilitate adequate interactions of particles with the surface. 
Secondly, thiols can contribute to sticky interactions and hence the amount of thiols on the 
particles was lowered. However, neither of these strategies reduced fouling sufficiently to 
collect useful measurements.  
The stiffness of capsules is also dependent on the choice of polyelectrolyte and the 
number of the layers that constitute the capsule so a different selection of either of these 
could alter the results and highlights the difficulty of selecting fabrication conditions and 
comparing to the literature. For example, capsule elasticity was greater by 3.5-5 times when 
poly(allylamine hydrochloride) was the choice of polyelectrolyte over poly(diallyldimethyl 
ammonium) chloride for capsule formation with poly(styrene sulfonate sodium salt)168. An 
increase in the number of layers has been correlated to increased stiffness of capsules in 
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the case of poly(styrene sulfonate)/ poly(allylamine hydrochloride) and hyaluronic acid 
capsules58,59. In addition, it has been suggested through modeling that the stiffness ratio 
between the particle and the membrane, is critical in dictating either partial wrapping or 
complete wrapping by the cell169. It is possible that our particular materials system could 
be beyond this critical ratio for the cell type we are using and thus not influencing the 
interaction between capsules and the membrane. However, as discussed below, the 
difference between core-shell particle and capsule stiffness does play a role in 
internalization of rod-shaped particles, which underscores the complexity of the 
interactions and difficulty in making broad conclusions. 
When size and stiffness are altered for a spherical shape, our results show that a 
larger size and decrease in stiffness reduces internalization but also that altering the size 
plays a dominant role compared to stiffness in affecting internalization. This could depend 
on the crucial role of size in governing the number of attachment points of the particle to 
the cell and the energetics required for engulfment7,165. Altering the stiffness can affect the 
ability of actin cup formation, leading to reduced internalization154. Though the influence 
of stiffness in our case is negligible, the adhesion strength between the particle and the 
membrane for a particular stiffness could be explored with our particles to achieve full or 
no wrapping by macrophages. Models for relatively stiff particles have established that 
altering the adhesion strength alone can help achieve either no wrapping or full 
wrapping169.   
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Figure 3.9. A) Role of size and stiffness on internalization: core-shell (black), capsule 
(gray). Data represented as mean +/- standard deviation (n = 3). B) P values calculated 
for each source of variation by two-way ANOVA. 
 
Figure 3.10. Confocal microscopy images from the center of the stack of J774 cells 
incubated with particles for one hour: A) 3 µm capsule (scale bar 5 µm), B) 6 µm 
capsule (scale bar 10 µm). 
3.2.2.5 Interplay between shape and stiffness of spherical particles 
To understand the effect of shape and stiffness, spheres and rods of identical 
volume were used. As seen in Figure 3.11, both the shape and stiffness together affect 
internalization (interaction shape*stiffness p = 0.023). When we look at the individual 
effects of shape for core shell particles in Figure 3.11, switching from sphere to rod shape 
decreases internalization while it has no effect on capsule rods and spheres. Studies have 
elucidated that shape of a particle can influence attachment to and internalization by a 
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macrophage independently 35. Prolate ellipsoids have been shown to achieve maximum 
attachment compared to sphere and oblate ellipsoids. However, oblate ellipsoids exhibited 
higher internalization when compared to these two shapes. In another study, antibody-
displaying micro-rods were shown to exhibit higher attachment and uptake compared to 
spheres in breast cancer cells36. The data in Figure 3.8 suggests that the rod shaped core-
shell particles are able to attach to the macrophage but are unable to efficiently convert 
attachment into internalization. Our prior work with core particles hypothesized this was 
due to minimized curvature at the point of contact153. Switching the shape from sphere to 
rod has no effect on internalization of capsules. As evident from the analysis, this 
difference from core-shell particles must be due to the combined effects of shape and 
stiffness. Our results contradict a previous study where PMA spherical capsules were 
shown to be internalized more than rod shaped capsules73. This could be due to the different 
size (~300 nm) and mechanism of internalization, or the type of capsules and cells used, 
which make comparison difficult.  
When we isolate the role of stiffness in these interactions; for 3 µm spheres, altering 
stiffness seems to have no effect on internalization. However, decreasing stiffness of rods 
has a significant 2.6-fold increase in internalization. The reduced stiffness of the rods 
enables their bending and twisting by the cell upon internalization, as seen in Figure 3.12. 
The stiffness of anisotropic particles is dependent on their orientation during interrogation 
methods like atomic force microscopy170,171. In the case of hollow tubes made from glass 
fiber templates, the stiffness varied with the location of probing on the tube, highlighting 
the challenges involved in characterizing mechanical properties of anisotropic shapes. 
Recently, a non-contact mode of determining axisymmetrical pendant capsule elasticity 
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was developed based on the pendant drop method. This method determines the capsule’s 
resistance to stretching and its bending stiffness from shape and wrinkle analysis during 
deflation of the capsule172. However, it may not be possible to analyze different geometries 
through this method. Models to establish the global bending of shaped capsules like tubes 
is actively being pursued173. Such investigations can help identify the dependence of 
elasticity on shape. Another aspect to be considered when comparing core-shells and 
capsules is the density differences between these particles, as this physical property affects 
the ability of feeders such as ciliated protozoa to efficiently capture particles174. Though 
the mechanisms of encountering particles are different between these cells is different, the 
number of particles that are associated can be influenced by this parameter. The similar 
total association trends between these type of particles in Figure 3.8, suggests that particle 
density is not influencing macrophage interactions. 
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Figure 3.11. Role of shape and stiffness on internalization: core-shell (black), capsule 
(gray). Data represented as mean +/- standard deviation (n = 3). (p = 0.044 for shape, p = 
0.026 for stiffness, p = 0.023 for shape*stiffness, by two-way ANOVA followed by Sidak’s 
multiple comparison test).  
 
 
Figure 3.12. Confocal microscopy images from the center of the stack of rod capsules 
incubated for one hour with J774 cells: A) bent rod and B) rod folded in half (dotted arrow), 
twisted rod (solid arrow), scale bar 10 µm. 
Varied stiffness has a complex interaction with shape, affecting internalization in 
the case of rods while having negligible effect on spheres. Particle shape has been widely 
investigated to alter cellular attachment and internalization of particle based 
therapeutics35,37,153. Oblate ellipsoids were found to be internalized more than prolate 
ellipsoids or spheres during phagocytosis35. A 2D model for phagocytosis of non-circularly 
symmetric particles predicts similar results for oblate ellipsoids when presented on the flat 
side to the macrophage membrane175. Despite the usual convention of high particle 
curvature promoting fastest engulfment, the model suggests that orientations like the flat 
side of oblate ellipsoids can also promote uptake. The mechanism of this is still to be 
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investigated. In another study, BSA coated poly (allylamine hydrochloride)/ 
poly(styrenesulfonate) bowl-like microcapsules were found to be internalized greater than 
spherical microcapsules in smooth muscle and macrophage cells. Bowl-like capsules were 
found to mainly attach to cells from the convex-side, and it was hypothesized that less 
energy expenditure is required for membrane deformation and that facilitates enhanced 
uptake of these capsules over spherical shapes74. Though the field does not yet have a 
unified theory, these studies contribute to the role of shape and orientation of the particle 
in enhancing uptake.  
The effect of particle elasticity on cellular interactions, to a certain extent, shows 
consensus for immune cells that soft spherical or non- spherical particles are internalized 
to a lesser extent than their stiffer controls53,54,56,154. TA/PVPON cubical or spherical 
microcapsules exhibited less uptake in macrophages compared to their respective stiff 
counterparts. In addition, no difference in uptake between spherical or cubical stiff core-
shells was reported, highlighting that a cubical shape for stiff core-shells has no effect on 
internalization. Reduced stiffness in this case worked in concert with shape (cubical or 
spherical) to reduce internalization by macrophages, emphasizing the complex interaction 
that stiffness can have on internalization for different shapes 54. In the case presented here, 
internalization by macrophages is enhanced due to a combination of non-spherical, rod 
shape and reduced stiffness. For two particles of the same volume, an increase in surface 
area increases the probability of adhesion when comparing rods and spheres. This increase 
in adhesion contact area will also enhance the interaction between the particle and 
membrane, facilitating full wrapping through adequate compensation of membrane 
bending176. In addition to shape,  reduced stiffness can increase the ability of the 
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macrophage to feel the particle by deformation, causing changes in the local curvature of 
the particle at the point of attachment177,178. This can facilitate wrapping by the cell 
membrane, resulting in enhanced internalization of shaped capsules over their 
corresponding core-shells. These tunable particles thus highlight the interplay between 
physical properties size, shape and stiffness to alter cellular interactions. 
3.3 Summary 
The results in this chapter illustrate the development of a system where the effect of 
multiple physical properties on cellular interactions can be evaluated. Using these particles, 
we have analyzed the effects of size, shape and stiffness on macrophage interaction and 
internalization. Stiff core-shell particles of the same volume but different shape, exhibit 
very different trends in internalization when compared to capsules. Core-shell rods reduced 
internalization compared to core-shell spheres, while capsule rods behaved quite similarly 
to spherical capsules.  
Though these properties have an individual effect on cellular interactions, the way 
each of these influence interactions changes when they work in concert with other 
properties. In our results it is evident that stiffness behaves in a complex way when 
combined with size or shape. Increase in size reduces internalization of spherical particles, 
while changes in stiffness have no effect. However, varying stiffness had a significant 
effect on internalization for rod shaped particles. These results reveal the complex interplay 
between physical properties and highlight the challenges in making broad conclusions 
about the roles of size, shape, and stiffness on phagocytosis, as is evident from the 
seemingly conflicting reports in the literature. This system can be used to fabricate 
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advanced carriers or understand membrane mechanics and can be leveraged to identify 
combinations of properties that improve particle-based delivery systems or reveal new 




CHAPTER 4. IMMOBILIZATION OF STEALTH 
PHOSPHORYLCHOLINE COATING ON PARTCILES  
Micro and nano-particles when used in biological applications such as drug delivery 
come into contact with biological fluids that contain a complex mixture of proteins that can 
adsorb on the particle surface.  This adsorption process facilitates their clearance from the 
body by the cells of the reticuloendothelial system like the macrophages. The most 
common approach- PEGylation of materials suffers from drawbacks like initiation of an 
immune response when introduced into the body through the production of anti-PEG 
antibodies and complement activation45,46.  
Zwitterionic polymers containing phospholipids such as phosphorylcholine (PC) are 
alternative coatings that are being used for various biological applications 179. PC is a 
component of the cell membrane and is known to be non-thrombogenic180. 2-
methacryloyloxyethacrylate-PC (MPC) based polymers have been synthesized to mimic 
the cell membrane and have been shown to be highly resistant to adsorption of proteins181 
and adhesion of mammalian cells182 and bacteria183. It has been proposed that the PC group 
strongly associates with several water molecules through electrostatic interactions, 
enabling formation of a hydration layer that inhibits protein adsorption45,46. MPC surfaces 
have been generated either as self-assembled monolayers on gold substrates or as alcohol-
based coatings on medical devices such as cardiovascular stents, oxygenators, catheters, 
artificial blood pumps and blood filtration devices152,184. Though MPC polymers exhibit 
desirable properties when used as coatings for surfaces or particles in biological media, the 
techniques described require specific design of MPC co-polymer, as well as identification 
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of suitable solvents and process parameters to achieve sufficient coating. It would be 
beneficial to self-assemble MPC polymers as a layer on particles without such restrictions. 
In this chapter, an alternative and general method has been developed.  This method 
is based on solvent composition enabling the self-assembly of MPC polymer as seen in the 
previous chapters. We show the assembly and characterization of a positively charged 
MPC polymer coat on model polystyrene microparticles by the simple ethanol coating 
process. We investigated the resistance of the assembled MPC coating to protein adsorption 
and phagocytosis, and compared its effectiveness to PEG conjugated microparticles. Our 
results show that, MPC coated particles exhibited reduced protein adsorption and 
macrophage internalization; as low as PEG conjugated particles. In addition, these particles 
demonstrate a balanced charge on their surface which further confirms their non-fouling 
nature.  
4.1 Experimental methods  
4.1.1 Phosphorylcholine coating on particles  
Poly(2-(methacryloyloxyethyl)-2-(trimethyl-ammoniumethyl)phosphate,inner salt 
/ 3-(2-amminoethylsulfanyl)-2-hydroxypropyl methacrylate hydrochloride) (MPCAM 
)was a generous gift of NOF Co. Ltd. (Tokyo, Japan). 18 mg of MPCAM polymer (5 wt% 
in water) was added to 1 ml of an 80% ethanol-water solution (Sigma Aldrich). 1.64 mg of 
carboxyl functionalized 3µm particles (Polysciences) were added to the solution and 
sonicated for 15 min. The particles were centrifuged at 5000g for 3min Allegra X-15R 
Centrifuge (Beckman Coulter), washed twice in phosphate buffered saline (PBS, 10 mM 
NaH2PO4, 137 mM NaCl, 2.7 mM KCl, 2mM KH2PO4; pH 7.4), and stored at 4°C 
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4.1.2 Polyethylene glycol conjugation on particles  
1.64 mg of carboxyl-functionalized particles was washed twice in 0.1 M 2-(N-
Morpholino) ethanesulfonic acid hydrate (MES buffer,pH 5.5, Acros Organics). The 
activated particles were then suspended in 0.1 M MES buffer containing 8 mM Sulfo-NHS 
and 15 mM EDC and reacted for 15 min. Then, 0.625 mM PEG was added to the solution 
and the reaction was continued overnight at 4°C. The particle suspension was centrifuged 
at 7500g for 5 min and washed twice with PBS and stored at 4°C  
4.1.3 Characterization of Particles  
Zeta potential was determined by measuring the electrophoretic mobility of 
particles in 10 mM sodium chloride (BDH) using Zetasizer Nano ZS90 (Malvern 
Instruments Ltd.). The existence of 2-methacryloyloxyethyl phosphorylcholine (MPC) 
groups on the particle surface was confirmed by X-ray photo- electron spectroscopy (XPS; 
Thermo K-Alpha XPS). A small drop of MPCAM coated particles was placed on a glass 
slide and allowed to dry for 24 hours prior to XPS characterization. 
4.1.4 Ovalbumin Adsorption on Particles  
MPCAM coated, PEG conjugated, and carboxyl uncoated particles (14.9 μg each) 
were incubated with 0.01 mg/ml fluorescent Alexa 647 ovalbumin (OVA, Life 
Technologies) for one hour. The particles were spun down at 7500g for 5min and washed 
twice with PBS. The particles were interrogated by a flow cytometer (Accuri C6, Beckton 
Dickenson Biosciences) to monitor any increase in particle fluorescence due to OVA 
adsorption. 
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4.1.5 Ovalbumin Adsorption on Particles at High Concentration Condition  
MPCAM coated, PEG conjugated, and carboxyl uncoated particles (0.149 μg each) 
were incubated with 10.01 mg/ml OVA protein solution for twenty-four hours at room 
temperature. The OVA protein solution was a combination of fluorescent and non- 
fluorescent OVA. The fluorescent OVA constituted 0.1% of the total OVA protein by 
mass. The particles were spun down at 17900g for 10 min and washed twice with PBS. 
The particles were interrogated by a flow cytometer to monitor any increase in particle 
fluorescence due to OVA adsorption. 
4.1.6 Stability of MPCAM Coating on Particles  
The stability of the MPCAM coating on particles was tested in PBS buffer. The 
particles were left in PBS for four weeks at 4°C and their effectiveness against OVA 
adsorption was tested as described above and compared to PEG conjugated particles. 
4.1.7 Adsorbed OVA Secondary Structure 
Circular dichroism (CD) spectra were acquired on a Jasco J-810 spectrometer 
(Easton) with the sample chamber maintained at 25°C. Measurements were made using a 
0.2 mm path length quartz cell. The average spectra of five measurements were obtained 
from a wavelength range of 200-250 nm with 1 nm increments. PBS without protein was 
used as a blank. Spectra for ovalbumin (OVA) (0.01 mg/ml) were measured in solution 
and in the presence of MPCAM coated, PEG conjugated, and carboxyl uncoated particles 
(0.07μg each). The particle concentration was optimized to reduce scatter and absorbance. 
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OVA and particles were incubated for one hour prior to acquisition. Spectra were acquired 
in millidegrees and converted to mean residue ellipticity using the following equation.  
 
The mean residue ellipticity in units of degrees cm2/dmol ([θ]) is a function of the 
observed signal in millidegrees, [θ]obs , the average molecular weight of the protein (MW), 
path length in cm (l), protein concentration in g/L (C), and the total number of amino acids 
(n). Estimation of secondary structure content was performed with the CDSSTR program 
provided in the CDPro software package. 
4.1.8 Phagocytosis Assay 
Cells were seeded in 24 well plates at a concentration of 105 cells per well and were 
allowed to adhere overnight. Particles (MPCAM coated, PEG conjugated, carboxyl 
uncoated) were added to cells in supplemented media at 10 particles/cell and incubated for 
two hours at 4°C. After cold incubation, samples were moved to 37°C, 5% CO2, 
humidified for one hour. Cells were then scraped from the wells, washed three times with 
cold PBS to remove unattached particles and analyzed by flow cytometry. For serum 
independent experiments, particles were incubated with OVA for one hour and 
subsequently added to cells in serum free media with the same incubation procedure 
described above. 10,000 cells were counted in each condition and was repeated with freshly 
coated particles. 
4.1.9 Statistical Analysis  
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All quantitative experiments were performed in triplicate and are presented as 
arithmetic mean ± SD. Phagocytosis assay was performed in duplicate. One-way ANOVA 
was used to determine significance among groups. p values <0.05 among groups were 
considered statistically significant.  
4.2 Results and discussion 
4.2.1 Fabrication of phosphorylcholine coated, polyethylene coated particles 
Carboxyl 3 µm polystyrene particles were used as model particles. Poly (2-
(methacryloyloxyethyl)-2-(trimethyl-ammoniumethyl) phosphate, inner salt/3-(2-
amminoethylsulfanyl)-2-hydroxypropyl methacrylate hydrochloride) (MPCAM, 
Appendix B) (a kind gift of NOF Co. Ltd.) was assembled on the particles by incubating 
them in a 2 wt% polymer solution containing 80% ethanol. Polymer with MPC content of 
85 mol% was used in this work. It has been shown that polymer with 50 mol% MPC is 
sufficient to prevent protein adsorption on flat surfaces182. Carboxyl particles were also 
conjugated with PEG MW 5000 through EDC-NHS conjugation chemistry. PEG MW 
5000 has been established as the critical molecular weight threshold for maximum 
reduction in protein adsorption and was thus used in this study for comparison to 
MPCAM185. Zeta potential measurements confirmed coating of MPCAM polymer and 
conjugation of PEG on carboxyl particles. The zeta potentials of particles, measured in 10 
mM NaCl, were +22.1 +/-3.28, -8.1 +/-3.57, and -70 +/-6.20 for MPC coated particles, 
PEG conjugated particles, and carboxyl uncoated particles, respectively. The PEG 
conjugated particles are neutral, consistent with high surface coverage148,186. Conversely, 
MPCAM coated particles are positively charged. This is attributed to the protonization of 
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the amine groups present in the copolymer of the MPCAM polymer. This indicates that the 
MPC coating has shielded the charge of carboxyl groups on the polystyrene particle. 
4.2.2 Determination of fouling by proteins on MPCAM particle surface  
When exposed to serum proteins, polymeric micro and nanoparticles develop a 
protein corona on their surface187. This corona is dominated by albumin, as it is abundantly 
present in serum. Fluorescently tagged OVA was used as a model serum protein. Figure 
4.1(A) shows fluorescence intensity of particles measured by flow cytometry after 
incubation with 0.01 mg/ml OVA for one hour. In comparison to carboxyl uncoated 
particles, OVA adsorption was reduced by 80% on the MPCAM coated particles (Figure 
4.1(B)), similar to the reduction in OVA adsorption observed for PEG conjugated particles. 
The MPC polymer forms a strong hydration layer via electrostatic interactions that plays a 
major role in preventing protein adsorption188. It has been established in the literature that 
PEG chains associate with water molecules to help achieve protein resistance185. Carboxyl 
uncoated particles exhibited high OVA adsorption due to hydrophobic interactions 
between the exposed polystyrene surface and protein. 
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Figure 4.1. OVA adsorption measured by particle fluorescence after one hour of 
incubation with Alexa-647 OVA at room temperature. (A) MPCAM coated (blue), 
PEG conjugated (black), carboxyl uncoated (red) particles upon OVA adsorption 
directly after particle coating. (B) Normalized OVA fluorescence of particles was 
obtained with respect to adsorption on carboxyl particles. The median fluorescence 
value of particles from (A) was normalized with respect to median fluorescence value 
of carboxyl particles upon OVA adsorption. 
4.2.3 Determination of stability of MPCAM coating on particle surface  
We next assessed the stability of MPCAM coated particles. OVA adsorption was 
tested after storing particles for 4 weeks in PBS at 4°C. As seen in Figure 4.2(A), their 
effectiveness in preventing adsorption was preserved and comparable to PEG conjugated 
particles. We also tested MPCAM coated, PEG conjugated and carboxyl uncoated particles 
after 6 months storage in PBS at 4°C, in a high (10 mg/mL) concentration of OVA and a 
longer time period of incubation with the protein (Figure 4.2B). We observed similar 
results as in Figure 4.2(A). This demonstrates that although there is no covalent interaction, 
there is a strong association between the adsorbed MPCAM polymer and particle surface. 
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Figure 4.2. Stability of MPCAM coating measured by fluorescent OVA adsorption on 
particle surface. (A) MPCAM coated (blue), PEG conjugated particles (black) and 
carboxyl uncoated (red) particles after storing for 4 weeks in PBS at 4°C (B) MPCAM 
coated (blue), PEG conjugated (black), Carboxyl (red) particles upon OVA 
adsorption after storing in PBS for 6 months at 4°C. Fluorescent OVA adsorption 
measured by particle fluorescence after twenty-four hours of incubation with a high 
concentration mixture of fluorescent and non-fluorescent OVA at room temperature.  
4.2.4 Determination of fouling by proteins on MPCAM particle surface  
We probed the influence of coating on OVA secondary structure upon adsorption to 
MPCAM coated, PEG conjugated, and carboxyl uncoated particles. Adsorption of serum 
proteins on the surface of polymeric particles often alters protein structure150. Structural 
changes can influence the type of cell receptors engaged by adsorbed proteins during 
particle-cell interactions. In a recent study, it was established that the secondary structure 
of adsorbed protein is influenced by the surface chemistry of nanoparticles and alters 
interactions between particles and cell receptors150. Cationic amine and anionic carboxyl 
nanoparticles have been shown to exhibit net anionic protein-NP complexes on their 
surfaces when in contact with serum. However, there is a loss in secondary structure of 
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proteins on cationic, but not anionic nanoparticles. Further this loss in secondary structure 
caused alternate receptor engagement189. Such alternate engagement by receptors can result 
in inflammatory responses190. Circular dichroism (CD) spectroscopy was used to determine 
the structural content of OVA following incubation with particles for one hour. OVA 
incubated with MPCAM coated, PEG conjugated, and carboxyl uncoated particles showed 
similar α-helical content to soluble OVA, suggesting no significant change in OVA 
secondary structure. All surfaces, including MPCAM coated particles, support retention of 
adsorbed protein secondary structure as seen in Table 4-1. It has been reported that proteins 
adsorbed to PEGylated nanoparticles do not exhibit loss of secondary structure191. Surface 
carboxylation of particles also helps in retaining protein secondary structure upon 
adsorption 150. 
Table 4-1. Secondary structure content of OVA in the absence and presence of 
particles obtained using the CDSSTR program with raw CD data. 
 
4.2.5 Influence of MPCAM coating on particle uptake by macrophages  
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Evasion of immune cells is a primary challenge for particle based therapeutics192. 
We investigated the ability of MPCAM coated and PEG conjugated fluorescent particles 
to suppress uptake by J774A.1 mouse macrophage cells. Uptake by J774A.1 was 
performed in 10% serum (equivalent to 10mg/ml of protein193) representing biological 
conditions requiring high concentration of protein. To understand the influence of serum 
proteins on uptake, serum-free incubation of cells and particles (MPCAM coated, PEG 
conjugated, carboxyl uncoated) was carried out following incubation of particles with 
OVA. Just as MPCAM coated and PEG conjugated particles exhibited similar OVA 
adsorption (Figure 4.1A), they also had similar resistance to phagocytosis in serum-free 
conditions (Figure 4.3). There was no difference in uptake by macrophages when the media 
was supplemented with media for either MPCAM coated or PEG conjugated particles as 
seen Figure 4.3. However, carboxyl uncoated polystyrene particles are hydrophobic and 
are taken up by macrophages to a significantly greater extent. There was no difference in 
phagocytic uptake in the presence or absence of serum proteins, indicating no role of serum 
proteins on phagocytosis.  
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Figure 4.3. Percent internalized particles after incubation with macrophages at 37°C 
for one hour. Media was not supplemented with serum and particles were incubated 
with OVA for one hour prior to incubation with macrophages (black), or media was 
supplemented with 10% (v/v) fetal bovine serum (gray). 
4.2.6 Surface characterization of MPCAM coated particles  
Though MPCAM coated particles have a positive zeta potential, which the 
literature would predict to result in poor performance, the data indicate that MPCAM 
coated particles resist protein adsorption and phagocytosis as well as covalently bound 
PEG 5000. Surfaces with positive zeta potential are known to induce protein adsorption. It 
has been shown that negative or neutral nano and microparticles have lower levels of 
protein adsorption and internalization than positively charged particles6,194–196. However, 
in a biological environment, irrespective of the surface functionalization, particles display 
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a negative charge on their surface resulting from protein adsorption136. Zeta potential alone 
is not sufficient to establish how the interactions of particles and cells are influenced by 
surface functionalization and protein adsorption. X-ray photo-electron spectroscopy (XPS) 
characterization is commonly used to characterize zwitterionic coatings197. The non-
fouling nature of zwitterionic surfaces is determined by the nitrogen to phosphorus or N/P 
ratio. This ratio indicates the charge balance for a surface. A ratio of N/P = 0.87 was shown 
to resist fibrinogen adsorption effectively on a PC thiol self-assembled monolayer197. 
Further, the study demonstrated that such ratios could serve as an indicator of the non-
fouling nature of the surface. XPS elemental analysis of MPCAM coated particles shown 
in Table 4-2 revealed a ratio of N/P= 0.89. This ratio further supports the non-fouling nature 
of the MPCAM coated particles. 
The XPS data supports that the PC groups are exposed to the surface. It has been 
proposed that PC groups on the surface can help in reducing the interfacial energy when in 
contact with water198. The hydrophobic moieties of the co-polymer might be buried within 
the assembly of the polymer and thus the MPC groups are oriented in aqueous 
environments to dominate the surface chemistry198. The electrostatic interactions between 
the charged groups on the co-polymer and proteins do not appear to play a significant role. 
However, the co-polymer could aid in the assembly of the MPC polymer. We hypothesize 
that the solvent quality enhances the hydrophobic attraction between the MPCAM polymer 
and the polystyrene surface. It has been established that for zwitterionic polyelectrolytes in 
poor solvents, as ethanol is for MPCAM polymer, the change in their conformation 
facilitates such hydrophobic attraction199,200. Therefore, this technique could be further 
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extended to other hydrophobic particles used in biological applications such as poly (lactic-
co-glycolic acid) or polycaprolactone. 
Table 4-2 Elemental characterization by XPS of MPCAM coated particles. 
 
4.3 Summary 
The results in this chapter illustrate the potential of ethanol based layer-by-layer 
technique in immobilizing stealth coatings on particles. We demonstrate a simple technique 
of assembling a positively charged MPC polymer on model polystyrene particles through 
the 1-step ethanol coating process. Our results show that, despite positive zeta-potential 
protein adsorption and macrophage internalization were low for MPCAM coated particles; 
as low as for PEG conjugated particles. Balanced charge on the surface dictates the 
behavior of zwitterionic non-fouling surfaces and the N/P analysis ratio of MPCAM coated 
particles confirmed balanced surface charge. MPCAM coated particles retained adsorbed 
protein secondary structure, which is a critical design benefit that can influence the 
interactions of particles with cells and other proteins for diagnostic and therapeutic uses. 
This technique can be extended to biological applications that are incompatible with 
covalent coating methods, such as backfilling of particle surfaces to prevent protein 
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adsorption while retaining the targeting ability of attached ligands, or to endow stealth 




CHAPTER 5. THE ROLE OF GEOMETRIC PRESENTATION 
OF LIGANDS ON MACROPHAGE INFLAMMATORY 
CYTOKINE RESPONSE 
Biomaterials such as nano- and micro particles have been developed to tailor 
immune responses. These materials are being used to enhance vaccine responses to 
pathogens, drug delivery to inflamed cells, and modulate inflammation in an antigen-
specific or non-specific manner201. New strategies are actively being explored to control 
the immune system by enhancing or suppressing immune functions, and particle properties 
play a key role in programming biologic responses. Particle physicochemical properties 
such as size7,52,202, shape34,54,92, surface chemistry150,203, ligand density52,107, surface 
topography204 have been identified as crucial in governing cellular responses in a wide 
range of cell types. In addition, these properties have the ability to determine the type of 
immune response92,202. Immune cells and functions, in particular, appear to be quite 
sensitive to particle properties92,124,153. 
Shape of the particle when functionalized with active ligands not only replicate 
native immune interfaces but also augment interactions and initiate signaling from cognate 
receptors on immune cells of interest 92,102,153. While the field has made tremendous 
progress in understanding the effect of particle physicochemical properties on the outcome 
of particle-macrophage interactions, it is unclear how macrophage functions like cytokine 
production are affected while presenting active ligands through altered physical properties. 
Moreover, it is unknown if geometric ligand presentation through an altered particle shape 
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can elicit differential macrophage cytokine responses and if responses are ligand 
dependent. 
In this chapter, we investigated the influence of geometric presentation of varying 
ligands (BSA, IgG, OVA, CD200) facilitated by the manipulation of shape of the particle 
on macrophage inflammatory cytokine response- TNF-α. In addition, we examined the role 
of geometric presentation of different ligand densities between varying shapes and 
correlated to TNF-α secretion and total particle association. Evidence indicates that, 
presentation of diverse ligands on rod shaped particles is inflammatory to macrophages 
compared to the same ligands presented on spherical shaped particles. This effect was 
observed for varying ligand densities and does not correlate to total particle association. 
This study demonstrates the ability of geometric manipulation of ligands to alter 
macrophage cytokine response irrespective of the nature of the ligand. 
5.1 Experimental methods  
5.1.1 Fabrication of rod shaped particles  
Our previously reported method was used to fabricate rod shaped particles32. 
Briefly, 1 ml of 2.6 wt% fluorescent or plain polystyrene spheres (Polysciences) was 
suspended in PVA solution (0.1 g/ml, hydrolyzed degree 99+%, Mw = 85-124 kDa, Sigma-
Aldrich) and the solution was dried to yield a film of thickness of ~65 µm. The film was 
stretched in a hot oil bath maintained at 120˚C to an aspect ratio of 2.5. The film was cooled 
to room temperature and the particles were extracted from the film by heating the film in 
30% IPA-water solution maintained at 65˚C. The particles were collected by centrifugation 
at 2500 g using an Allegra X-15R Centrifuge (Beckman Coulter) for 15 minutes. This 
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process of washing was repeated at least 7 times to remove all PVA from the particle 
surface. 
5.1.2 Ligand functionalization of particles  
Plain or fluorescent particles (spherical or rod-shaped) were coated with BSA 
(Fischer Scientific) or OVA (Invivogen ) using 10 times excess or with human IgG1 (R & 
D Systems) using 20 times excess of the surface monolayer saturation as calculated from 
the manufacturer’s protocol.  
5.1.2.1 BSA and IgG functionalized particles  
The particles were incubated with BSA (1 mg/ml) in PBS for two hours, washed 
three times in PBS and collected by centrifugation. To functionalize with IgG, BSA coated 
particles were further incubated for one hour with rabbit anti-BSA IgG (Life 
Technologies); antibody at a mass ratio of 1:1 (BSA:IgG). For variable IgG density on 
particles a dilution of 1:5 or 1:100 of IgG to BSA was used. The IgG functionalized 
particles were washed three times with PBS. To confirm the presence of IgG, particles were 
incubated for 30 minutes with FITC goat-anti-rabbit IgG (BD Life Sciences) and washed 
with PBS three times. 
5.1.2.2 OVA functionalized particles  
The particles were incubated with OVA (1 mg/ml) in PBS for two hours, washed 
three times in PBS and collected by centrifugation. OVA coated particles were incubated 
for one hour with primary rabbit anti-chicken ovalbumin antibody at a mass ratio of 1:1 
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(OVA:IgG). To confirm the presence of OVA, particles were incubated for 30 minutes 
with FITC goat-anti-rabbit IgG (BD Life Sciences) and washed with PBS three times. 
5.1.2.3 CD200 functionalized particles  
The particles were first incubated with human IgG1 Fc antibody (100 µg/ml) for 
two hours, washed three times in PBS and collected by centrifugation. These particles were 
further functionalized with CD200-Fc (100 µg/ml, R & D Systems) for one hour and 
washed with PBS. The presence of CD200 was confirmed by incubation with rat anti-
mouse CD200:FITC (Bio-Rad) for 30 minutes, and washed with PBS three times. 
All centrifugation steps were carried out at 2500g for 5 minutes. Plain particles 
were used to confirm the presence of ligands to avoid overlapping fluorescence between 
fluorescent particles and secondary antibody. The washed particles were assessed by flow 
cytometry (Accuri C6, Beckton Dickenson Biosciences) to confirm the respective ligand 
functionalization. 
5.1.3 Cells 
J774 macrophages (American Type Culture Collection (ATCC)) were grown in 
Dulbecco’s Modified Eagle’s Medium (DMEM) (ATCC) at 37˚C in a humidified 
atmosphere containing 5% CO2. The media was supplemented with 10% fetal bovine 
serum (Seradigm) and 1% penicillin/streptomycin (Amresco). The cells were used between 
passages 4 and 15. 
5.1.4 Cytokine Assay  
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J774 cells were plated overnight at 105 cells per well in a 24 well plate. Plain or 
fluorescent ligand coated particles were added to the cells in supplemented media at 
concentration of 10 particles/cell. The cells were incubated with particles for eight hours. 
The supernatants were collected and stored at -80 ºC to measure TNF-α production. TNF-
α production was measured by standard ELISA kit (R&D Systems) as per manufacturer’s 
instructions. The cytokine assay was repeated three times using three different batches of 
particles. 
5.1.5 Particle association with cells  
J774 cells were plated overnight at 105 per well in a 24 well plate. BSA, IgG or 
OVA functionalized fluorescent particles were added to the cells in supplemented media 
at 10 particles/cell. After incubation for 8 hours, the cells were washed with cold PBS three 
times and scraped from wells. Cell populations were gated based on the side and forward 
scatter of J774 cells without particles. The number of particles per cell was determined by 
measuring the mean fluorescence intensity (MFI) of the curve and dividing by the average 
MFI of one particle205. The phagocytic assay was repeated two times and 10000 cells were 
counted in each condition.  
5.1.6 Cytokine assay for CD200 functionalized particles  
All protocols involving animals were in compliance with the NIH Guide for the 
Care and Use of Laboratory Animals, as well as with relevant laws and institutional 
guidelines as prescribed by Georgia Institute of Technology’s Institutional Animal Care 
and Use Committee. Femurs from 6 to 12 week old female C57BL/6J mice (Jackson 
Laboratory) were harvested following euthanasia. Mouse C57BL/6 cells obtained from 
 91 
bone marrow were treated with red blood cell lysis buffer (155 mM NH4Cl, 12 mM 
NaHCO3, 0.1 mM EDTA; pH 7.4). The cells were cultured in Dulbecco’s Modified Eagle 
Medium/F12 (DMEM/F12; Invitrogen) supplemented with 10% heat-inactivated FBS 
(Hyclone), 10 mM l-glutamine, 100U/ml M-CSF, 100 U/mL penicillin, and 100 µg/mL 
streptomycin. On day 7 of growth, the differentiated macrophages were dislodged using 
cell-dissociation buffer (Cellgro) after washing twice with Dulbecco’s phosphate-buffered 
saline without calcium or magnesium (Cellgro)206. Macrophage response was examined by 
seeding 1×105 of bone marrow derived macrophages (BMDM) in culture media described 
above in a 96 well plate. Macrophages were pre-incubated with particles at a particle: cell 
ratio of 10:1 for two hours and then stimulated with murine IFN-γ (0.5 ng/ml) and E.coli 
LPS (0.05 ng/ml, Sigma) for 18 hours. Cell culture supernatants were collected and 
analyzed for secretion of pro-inflammatory cytokine TNF-α, by ELISA following the 
manufacturer’s instructions (R&D Systems). The cytokine assay was repeated with freshly 
coated particles. 
5.1.7 Enhanced green fluorescent protein (eGFP) adsorption to shaped particles 
Spherical or rod shaped particles, 30000 in number were incubated with eGFP for 
15 minutes at room temperature. The particles were spun down at 2500g for 5 minutes and 
resuspended in PBS. The particles were then immediately interrogated on the flow 
cytometer. For heat denaturation experiments, eGFP coated particles from the previous 
step were added to a PBS solution maintained at 55∘C or 65∘C for 10 minutes. The solutions 
containing the particles were run on the flow cytometer. All experiments were repeated in 
triplicate. 
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5.1.8 Statistical analysis  
One-way or two-way ANOVA was performed followed by Tukey’s post-hoc test for 
multiple comparisons. p < 0.05 was considered to be statistically significant in all analysis. 
Statistics were performed using the GraphPad Prism6 software. 
5.2 Results  
5.2.1 Ligand functionalization on spherical and rod shaped particles  
Rod shaped particles were prepared by our previously developed method32. All 
ligands were immobilized by passive adsorption on the surface of spherical and rod-shaped 
particles. For ligands BSA and OVA direct adsorption on particles was carried out. For the 
case of IgG immobilization, the particles were first coated with BSA and then incubated 
with anti-BSA IgG antibody to orient the Fc portion of the antibody to relevant Fc receptors 
on macrophages. The coating of all ligands, BSA, IgG and OVA, was confirmed by 
incubation with relevant secondary antibodies and assessed with flow cytometry as seen in 
Figure 5.1. Irrespective of the ligand, similar levels of immobilization were observed for 
both spherical and rod shaped particles. 
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Figure 5.1 Ligand immobilization on spherical and rod shaped polystyrene particles. 
Spherical (blue) and rod (red) shaped particles were adsorbed with ligand A) BSA 
and rabbit anti-BSA IgG antibody B) OVA and rabbit anti-ovalbumin antibody and 
probed with the same fluorescein isothiocyante labeled anti- rabbit IgG secondary 
antibody to confirm BSA or IgG and OVA presence. Negative controls were 
incubated with BSA (A) or plain particle (B) and fluorescein isothiocyante labeled 
anti- rabbit IgG secondary antibody only. Plain PS particles (black) presented to 
indicate particle fluorescence. Traces were consistent across two independent 
replicates. 
5.2.2 Effect of geometric presentation of ligands on macrophage response 
The effect of presentation of ligands on varying shapes on inflammatory response 
was assessed with TNF-α production by macrophages. For the case of BSA, IgG and OVA 
coated spherical and rod shaped particles, TNF-α production was measured using the J774 
macrophage cell line by ELISA. Regardless of the type of ligand, TNF-α production was 
greater when ligands were immobilized on rods compared to spherical particles as seen in 
Figure 5.2. In addition, TNF-α secretion varied based on the identity of the ligand when 




Figure 5.2 Geometric presentation of ligands on spherical (s) and rod shaped (r) 
particles alters TNF-α production in J774 macrophages. TNF-α values are averages 
+/- standard deviation of n=3 and * denotes p<0.05 as determined by one-way 
ANOVA followed by Tukey’s multiple comparison test. 
5.2.3 Relation between varying IgG ligand density and geometric presentation on 
macrophage response  
BSA coated particles were exposed to varying concentrations of anti-BSA IgG 
antibody to alter the IgG ligand density on each shape. The reduced IgG densities are 
denoted as a ratio between BSA:IgG. Similar densities were maintained between shapes 
for a corresponding ligand density as seen in Figure 5.3.  
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Figure 5.3Variable IgG density on spherical and rod shaped particles. The histograms 
of fluorescent intensity of fluorescein isothiocyante labeled anti-rabbit IgG secondary 
antibody added to each a) spherical and b) rod shaped particle condition and 
measured by flow cytometer. The density is presented as a ratio between BSA:IgG in 
each condition. Traces were consistent across two independent replicates. 
We measured the amount of TNF-α produced for each IgG ligand density on the 
shapes by ELISA. Reducing IgG density on spherical particles did not influence TNF-α 
production by macrophages, as seen in Figure 5.4A. However, reduced IgG density on rod 
shaped particles correspondingly reduced TNF-α production in J774 macrophages. 
Presentation of matched IgG densities on rod shaped produced greater TNF-α production 
than when presented on spherical particles in all cases except the lowest IgG density, 100:1.  
Using variable IgG functionalized fluorescent spherical and rod shaped particles 
we assessed total particle association with J774 macrophages by flow cytometry. Total 
particle association is the combination of particles attached to and internalized by cells. 
Two-way ANOVA was used to determine the influence of both IgG ligand density and its 
presentation on varying shape on total particle association as seen in Figure 5.4B. 
Maximum IgG functionalization at a ratio of 100:100 increased the macrophage association 
of spherical particles compared to non-IgG-functionalized (BSA only coated) spherical 
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particles. Conversely, for rods, functionalization with IgG at the same maximum density 
(100:100) did not enhance total macrophage association in comparison to BSA coating. 
Altering IgG density on spherical particles had no influence on total particle association 
with macrophages. Conversely, reducing IgG ligand density to a ratio of 100:1 on rod 
shaped particles reduced uptake compared to the intermediate ligand density ratio of 
100:20 but not compared to the maximum ligand density of 100:100. Overall, similar total 
cellular association was observed for spherical and rod shaped particles at each variable 
IgG density.  
 
 
Figure 5.4 Effect of IgG ligand density and its presentation on spherical or rod shaped 
particles. A) TNF-α production and B) total association in J774 macrophages. A) 
Quantitative analysis of total particles associated with macrophages, including 
attached and internalized, at each ligand density when presented on spherical or rod 
shaped particles. * denotes p< 0.05 between groups as determined by two-way 
ANOVA with Tukey’s multiple comparison test in each condition. B) Concentration 
of TNF-α produced by macrophages at each ligand density when presented on 
spherical or rod shaped particles. Error bars indicate averages+/- standard deviation 
of n=3 and * denotes p< 0.05 between corresponding spherical and rod shaped groups, 
** denotes p<0.05 between 100:100 and 100:0 rod shaped groups and # denotes p<0.05 
between 100:1 and 100:100 or 100:20 as determined by two-way ANOVA with 
Tukey’s multiple comparison test. 
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5.2.4 CD200 immobilization and the effect of geometric presentation of CD200 
functionalized particles on macrophage response 
In contrast to the ligand coated particles in Figure 5.1, which appear foreign to 
macrophages, CD200, a self-ligand known for its anti-inflammatory nature, was 
immobilized on particles to further understand the role of geometric ligand presentation207. 
CD200 coated particles were produced by first functionalizing particles with anti-Fc 
domain, followed by CD200-Fc incubation with particles, as seen in Figure 5.5A. The 
effect of CD200 immobilization on varying shapes on TNF-α production was assessed in 
mouse bone-marrow derived macrophages since there is no literature evidence that 
macrophage cell line J774 responds to CD200. The role of geometric presentation on 
immune-inhibitory properties of CD200 was evaluated after pre-treating bone marrow 
derived macrophages with CD200 functionalized particles, followed by incubation with 
potent stimulators of inflammatory response: lipopolysacharide (LPS) and interferon-
gamma (IFN-γ). Despite the anti-inflammatory nature of CD200, immobilization on rods 
activated greater production of TNF-α in macrophages than spherical particles, as seen in 
Figure 5.5B. There was no difference in TNF-α production by primary macrophages 
between non-functionalized spherical and rod shaped PS particles. 
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Figure 5.5 Immobilization of anti-inflammatory ligand CD200 on shaped particles 
and effect of its geometric presentation on TNF-α production in primary mouse 
macrophages. (A) Spherical (blue) and rod (red) shaped particles were functionalized 
with CD200-Fc through prior incubation with anti-Fc IgG antibody and probed with 
secondary anti-mouse CD200 FITC labeled antibody to confirm CD200 presence. The 
negative control was incubated with anti-Fc and secondary anti-mouse CD200 FITC 
labeled antibody only. Plain PS particles (black) presented to indicate particle 
autofluorescence. Traces were consistent across two independent replicates. (B) 
Concentration of TNF-α produced by primary macrophages when incubated with 
CD200 coated particles. TNF-α values are averages +/- standard deviation of n=3 and 
* denotes p< 0.05 as determined by two-way ANOVA followed by Tukey’s multiple 
comparison test evaluating differences in TNF-α production due to particle coating 
on varying shape. 
5.2.5 Influence on structure of protein when adsorbed on shaped particles 
Enhanced green fluorescent protein (GFP) was used a model protein to evaluate the 
influence on change in protein structure upon direct adsorption to shaped particles. GFP is 
known to known to lose fluorescence upon denaturation due to structural changes in its 
barrel protected chromophore208,209. Rods adsorbed with GFP exhibited lower fluorescence 
than spheres (Figure S1A), Further, this lower fluorescence on rods was similar to 
fluorescence from GFP coated spheres denatured by heating to 55∘C. 
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Figure 5.6 GFP undergoes unfolding upon adsorption to rod shaped particles. A) 
Spherical (blue) or rod shaped (red) particles were incubated with GFP for 15 
minutes. B) Spherical or rod shaped GFP coated particles subjected to denaturation 
by heat. Curves represent GFP coated shaped particles: no denaturation (spherical: 
blue, rod: red) or denaturation at 55 ° C (spherical, orange) or 65 ° C (spherical, 
green). Plain particles (black) indicate bare particle autofluorescence. Traces were 
consistent across three independent replicates. 
 
5.3 Discussion 
The tunability of synthetic particles in the field of immune-engineering has led to the 
development of novel design strategies capable of tailoring an immune response201. One 
such strategy is to replicate native immune interfaces by the functionalization of particle 
surfaces with ligands to initiate signaling from cognate receptors on immune cells of 
interest. In addition to functionalization with a ligand of interest, particle shape can be 
manipulated to augment interactions with immune cells 102. However, little is known about 
the effect of presentation of diverse ligands on shaped particles to immune cells like 
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macrophages. Macrophages bridge the innate and adaptive immune responses by 
orchestrated secretion of cytokines and chemokines during their interaction with synthetic 
particles. Thus, our aim in this report was to determine whether geometric presentation of 
diverse ligands on differing shapes affected macrophage inflammatory response.  
 We made rod shaped particles from 3 µm spheres by our previously developed 
technique involving heat liquefaction and stretching 32. This allowed us to conserve the 
volume of the particles between the spherical and rod shapes, thereby negligibly affecting 
the surface area of the altered rod shape in comparison to the corresponding sphere. 
Therefore, functionalization of the spherical and rod shaped particles through passive 
adsorption resulted in similar ligand densities on both shapes (Figure 5.1, Figure 5.5A). 
We presented diverse ligands on these shapes, BSA, IgG, OVA and CD200, that interact 
with macrophages through varied receptors, scavenger, Fc, mannose and CD200R, 
respectively43,150,207,210,211. We determined the effect of geometric presentation of active 
ligands on macrophage inflammatory response by monitoring TNF-α production. TNF-α 
drives inflammatory responses through the activation of the NFκB pathway in cells212. We 
observed a significant enhancement of TNF-α secretion by macrophages when ligands of 
any type were presented on a rod shape compared to a spherical shape (Figure 5.2, Figure 
5.5B). Similar increased TNF-α production was reported for non-functionalized rod shaped 
PMASH capsules over spheres and for West Nile virus antigen coated cubic Au 
nanoparticles over spherical or rod shapes. While comparisons cannot be drawn, due to 
differing receptor engagement, particle sizes, and uptake processes between these studies 
and ours, they indicate that shape and ligand influence the magnitude of inflammatory 
response120,124.  
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TNF-α production was increased for rod shapes over spheres irrespective of the 
nature of the ligand, suggesting the importance of geometric presentation of ligands on 
varying shapes to immune cells. The functionalization of 3 µm spherical shaped PS 
particles with inflammatory ligands like IgG or OVA did not enhance TNF-α production 
by macrophages in comparison to BSA coated spheres (Figure 5.2). In the case of 1 µm PS 
spheres, IgG coating enhanced TNF-α production by unprimed macrophages compared to 
BSA coated particles213. However, in another study the ability of macrophages to induce 
differential cytokine response between ligands BSA and IgG was lost with increasing size 
(0.5 to 1 µm ) of spherical particles, suggesting the role of biophysical properties in such 
signaling214. In contrast, the amount of TNF-α produced when these ligands were presented 
on rods corresponded with the inflammatory nature of the ligand (OVA > IgG > BSA) 
(Figure 5.2). Further, there was no difference in TNF-α production between non-
functionalized spherical or rod shaped particles, despite non-specific adsorption likely 
from BSA and IgG from serum in the culture media (Figure 5.5B). This suggests that 
presence of a ligand on the surface is critical for altering inflammatory responses. In 
addition, with similar ligand immobilization levels between the shapes (Figure 5.2, Figure 
5.5A), these results demonstrate that the biophysical attributes of ligand presentation can 
influence innate immune signaling in macrophages.  
 Ligand density and particle shape can influence receptor signaling and uptake by 
cells 52,107. Especially in the case of macrophages, a high aspect ratio worm-like shape has 
been shown to inhibit phagocytosis34, while other shapes, like rods, can only be internalized 
from particular locations8. We therefore investigated the role of geometric presentation on 
the same ligand density for varying shapes and the influence of ligand density on a 
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particular shape on TNF-α secretion and total particle association. We chose total particle 
association with macrophages, which includes both attachment and internalization, as both 
these processes influence inflammatory responses during phagocytosis 215.          
Geometric presentation of all IgG ligand densities, except the lowest (100:1 
BSA:IgG), on rod shapes induced greater TNF-α production than the corresponding density 
on spherical particles (Figure 5.4A). However, there was no difference in cell association 
between spheres and rods with the same ligand density (Figure 5.4B). This is consistent 
with our previous study that reported similar total association between IgG coated 
polyelectrolyte spheres and rods216. These results indicate that the upregulation of TNF-α 
of rods over spheres is not due to an increase in cellular association with particles during 
phagocytic events.  
Inflammatory responses initiated by phagocytosis depend on the type of receptor 
engagement and subsequent phagosomal processing of the particle215. While receptor 
clustering and subsequent uptake is a hallmark for phagocytosis of particles, it is not known 
if the clustering of receptors varies when the shape of the particle is altered210. It is possible 
that shaped particles have a different pattern of clustering, which could also depend on the 
orientation of the particle with respect to the cell, thereby affecting signaling. In addition, 
the role of biophysical attributes of ligand presentation in signaling during phagosomal 
processing in macrophages is not known. In a recent study, despite similar acidification of 
varying sized OVA functionalized protein nanoparticles upon uptake in dendritic cells, 
medium sized (~ 350 nm) nanoparticles induced larger amounts of TNF-α secretion than 
small (~ 270 nm) or large nanoparticles (~ 560 nm)217. This suggests that particle size has 
the ability to alter cytokine responses during surface receptor-mediated pathways. Shape 
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has been shown to influence intracellular trafficking in other cell types. Elongated shaped 
poly(lactic-co-glycolic acid) microparticles, unlike spheres, were shown to be oriented 
tangentially when trafficked towards the nucleus of endothelial cells 218. In another study, 
disk shaped PS microparticles were shown to reside in pre-lysosomal compartments of 
endothelial cells longer than spherical particles219. Taking these size and shape examples 
together, it is possible that altered phagosomal processing of ligand coated rods influences 
inflammatory cytokine production.  
In addition to altered processing, the structure of the adsorbed proteins on the 
particle surface could also influence inflammatory cytokine production220. BSA and OVA 
functionalized rod shaped particles enhanced TNF-α production when compared to 
spheres (Figure 5.2, Figure 5.4A). This could due to a change in the structure of BSA or 
OVA upon direct adsorption to a rod shaped particle compared to a sphere. To test this 
hypothesis, spheres and rods were incubated with enhanced green fluorescent protein 
(GFP). GFP is known to lose fluorescence upon denaturation due to structural changes in 
its barrel protected chromophore208,209. Rods adsorbed with GFP exhibited lower 
fluorescence than spheres (Figure 5.6A), even though ligand functionalization levels 
between shapes were consistent for all ligands (Figure 5.1,  Figure 5.5A). Further, this 
lower fluorescence on rods was similar to fluorescence from GFP coated spheres denatured 
by heating to 55∘C, suggesting that GFP undergoes denaturation upon adsorption to rods 
(Figure 5.6B). In addition, it has been shown that albumin adsorption to shaped particles 
like gold nanorods221, and cubic222 or layered silicate nanoparticles43 leads to denaturation 
of albumin on the particle surface. In another study, denaturation of BSA upon adsorption 
to gold nanorods was observed but not for spherical nanoparticles221. While the surface 
 104 
chemistry between these two shapes was different, it is possible that both the shape and the 
surface chemistry of the particle contribute to this effect. Further, denaturation of protein 
on a particle surface has been shown to cause alternate receptor engagement and promote 
inflammatory cytokine production220,223. Denaturation of BSA on layered silicate particles 
has been shown to reveal cryptic epitopes that promote recognition of these particles 
through a specific macrophage scavenger receptor43 and could explain the different trends 
in TNF-α between spherical and rod shaped particles. In the case of IgG and CD200 
coated rods, it is possible that their denaturation is prevented as the anchor protein (BSA 
or anti-Fc IgG) is adsorbed first.  
We investigated how ligand density affected TNF-α and total particle association 
for a particular shape to help understand the differing response in TNF-α due to geometric 
presentation. Altering the IgG ligand density on spheres did not influence TNF-α 
production (Figure 5.4A). Similarly, varying the IgG density on 1 µm PS spheres did not 
affect TNF-α responses in macrophages214. The total association of spheres between 
100:100 or 100:20 and 100:1 BSA:IgG coating ratios were similar (Figure 5.4B). Again, 
this is consistent with a previous study that reported that the role of IgG density on 
macrophage interactions was negligible for PS spheres 3 µm and larger52. For the case of 
rods, a different trend was seen. Reducing the ligand density to a ratio of 100:1 decreased 
TNF-α production in macrophages (Figure 5.4A) when compared to ratios 100:20 and 
100:100. This data correlated to a decrease in total particle association when compared to 
the ratio 100:20 but not 100:100. While the TNF-α secretion in macrophages is impacted 
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by altering ligand density on rods, there is no direct correspondence between particle 
association and TNF-α production (Figure 5.4B).  
While BSA, OVA, and IgG ligands appear foreign to macrophages, we also 
investigated the role of geometric presentation for a self-ligand, CD200. CD200, like 
CD47, is a membrane protein and serves as a “don’t eat me signal” on a broad range of 
cells207,224,225. It ligates to CD200R present exclusively on myeloid cells and is known to 
deliver a strong inhibitory signal. Disrupting the CD200/CD200R interaction using 
CD200-knockout mice or blocking antibodies was shown to increase the number of 
infiltrating macrophages and susceptibility to autoimmune diseases, including collagen-
induced arthritis and experimental allergic encephalomyelitis226,227. In addition, 
administration of CD200-Fc fusion protein was shown to suppresses macrophage 
activation in a number of inflammatory diseases including arthritis 228, multiple sclerosis, 
229 influenza infection230 and organ transplantation231. The ability of CD200 to initiate these 
signals through surface interactions with its corresponding receptor motivated us to 
investigate if geometric presentation influenced its inhibitory behavior. Similar CD200 
functionalization levels were observed between spheres and rods, as seen in Figure 5.5A. 
The ability of CD200 functionalized particles to attenuate TNF- α secretion was tested in 
primary macrophages as there is no literature on the function of CD200, in J774 cell line 
macrophages.  
No difference in TNF-α production due to geometric presentation of CD200 was 
observed in the unstimulated conditions, which is in agreement with studies that indicate 
CD200 needs an inflammatory environment to exert any inhibitory influence. Similar 
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results were reported when primary macrophages were seeded on CD200 modified 
polystyrene surfaces; no influence of CD200 was observed until the cells were stimulated 
with inflammatory mediators109. When the macrophages were stimulated, TNF-α 
production was enhanced by geometric presentation of CD200 on rods compared to 
spheres. This suggests that presentation on rods was inhibiting the ability of CD200 to 
attenuate inflammatory responses. This could be due to overriding of CD200 self-signal 
when presented on a rigid, rod shaped particle, compared to a softer cell. The ability of 
physical properties shape and rigidity to override self-ligand signaling in macrophages has 
been recently established for self-ligand CD47 during erythrocyte phagocytosis 232.  
There was no difference in TNF-α produced by primary macrophages when 
exposed to non-functionalized spherical and rod-shaped PS particles in both the 
unstimulated and stimulated conditions as depicted in Figure 5.5B. This implies that the 
particles themselves are not inflammatory, in the absence of ligand functionalization. It is 
important to note that there was 10% serum present in the media in all experiments, so it 
is likely there was nonspecific adsorption of serum proteins onto non-functionalized 
particles, likely including BSA and IgG. However, for non-functionalized particles, the 
particle material chemistry may play a larger role since rod shaped PMASH particles were 
determined to be more inflammatory to unstimulated macrophages than spherical 
particles124.  
5.4 Conclusion 
In this chapter, we have examined the effect of geometric presentation of diverse 
ligands on macrophage inflammatory TNF-α cytokine production. Our results demonstrate 
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that presentation of ligands on rod shaped particles is inflammatory to macrophages 
compared to the same ligands presented on spherical shaped particles. This effect was 
observed for diverse ligands engaging varied macrophage receptors and for varying ligand 
densities. The degree of particle association with cells does not correlate with TNF-α 
cytokine production by macrophages and is not responsible for the shape effects seen. Our 
results indicate that particle shape can influence macrophage functions, such as cytokine 
production, when ligands are presented on the particle. The ability to program cell-particle 
interactions through geometric manipulation can be used as a strategy to influence 
immunological outcomes. Additionally, these results should inform ligand-targeted drug 
delivery particle design. A shape should be chosen that balances the goal of the application 
with any undesired immunological responses caused through the interaction of shaped 
particles with off-target cells like macrophages. 
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CHAPTER 6. CONCLUSIONS AND FUTURE OUTLOOK 
The work presented in this thesis focuses on engineering particles for tuning 
cellular interactions. Methods were developed to produce particles with controlled size, 
shape, stiffness, and surface chemistry. These particles were then used to probe how 
macrophage-particle interactions are impacted by these physicochemical properties, either 
alone or in combination. While the investigation of combinatorial properties is critical for 
advancing carrier designs, identification of the role of intrinsic particle properties is 
important to comprehend how the immune system responds to these particles. Particularly, 
we investigated the intrinsic role of shape on inflammatory responses, when presenting 
varied chemistries to macrophages. Thus, understanding the role of physicochemical 
properties through a combination of novel particle fabrication techniques and intrinsic 
particle property-cell response relationships could help design carriers to alter cellular 
outcomes based on the type of disease.  
The key findings in this work are: 
1. Soft templates possess the unique ability to be engineered in a wide variety of sizes 
and shapes. The development of the modified LbL technique based on hydrogen 
bonding using an organic solvent enabled the use of soft templates as a core 
material to create core-shell or hollow capsule particles. This method expanded the 
wide array of shapes that the versatile LbL process can be applied to and overcame 
issues such as aggregation that typically plague soft templates during LbL. 
2. The combination of modified LbL method on soft templates and thiol chemistry 
facilitated the development of a particle system whose physical properties size, 
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shape and stiffness can be tuned independent of one another while retaining the 
same surface chemistry.  
3. Particles with tunable physicochemical properties revealed the complex interplay 
between size, shape and stiffness in interactions with macrophages. Increase in size 
but not reduction in stiffness played a critical role in decreasing the internalization 
of spheres. Internalization of rod shaped particles but not spherical particles was 
highly dependent on stiffness. 
4. The modified LbL technique enabled a simple one step self-assembly process of a 
zwitterionic polymer that imparted stealth properties to particles and evaded 
macrophage uptake in vitro. 
5. The geometric presentation of active ligands was shown to affect inflammatory 
responses by macrophages. Particularly, presentation of ligands on rod shaped 
particles enhanced inflammatory cytokine responses by macrophages compared to 
spherical particles. 
The findings from this work illustrate the feasibility of using hydrogen bonded LbL 
on soft templates to manipulate multiple physical properties of particles. This system 
enables experiments to understand how cellular interactions can be altered when multiple 
properties are combined. This approach is modular, and other polyelectrolytes and biologic 
drugs could be incorporated to further tune the therapeutic outcome upon interaction with 
cells. The avenues opened through this modular nature are exciting for exploring the role 
of fundamental particle properties in biological milieu and extending this knowledge to 
applications involving biomaterial based tuning of cell responses. While this work helped 
in understanding the role of particulate stiffness in combination with other properties on 
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cellular interactions through qualitative measurements of particle stiffness, quantitative 
stiffness measurements have not been possible due to both experimental and data analysis 
limitations. Future work involving altered stiffness of anisotropic shapes should seek to 
obtain quantitative stiffness data on particles. Experimentally, passivation of the AFM 
probe might be beneficial. Data analysis between stiffness measurements of particles is 
challenging due to high variability, thereby making statistical interpretations difficult. In 
addition, establishing correlation of particulate stiffness induced biological changes in 
actin cup assembly during the phagocytic process can help establish how stiffness regulates 
this process.  
This work provides impetus to further investigate how the physico-chemical 
approaches to particle design can be manipulated to tune cell interactions based on 
fundamental properties. In addition, with the emerging applications of LbL in 
immunotherapy, future work needs to address clinical translatability of these materials. 
Some potential areas for investigation are as follows: 
6.1 Influence of surface topography on cellular interactions  
As evident from some studies77,233 and this work, LbL can be used to alter the 
surface chemistry of particles and affect the outcome of biological interactions. Another 
interesting property that can be tuned using this technique is the surface topography. The 
choice of polyelectrolytes in the LbL assembly process could cause changes in the 
roughness, thereby altering the surface topography of particles. The influence of surface 
topography of these multi-layered coated particles on influencing cell interactions has not 
been explored to the full extent. The interactions between these multi-layers can influence 
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not only the surface roughness but also the type, amount and conformation of proteins 
adsorbed234. Surface roughness has also been established as a critical parameter in 
influencing foreign body responses of biomaterials upon implantation235. Investigating the 
influence of this parameter would help in further influencing cellular outcomes from a 
material’s perspective.  
Recently, it was shown that the change in surface roughness due to varying 
polyelectrolyte layers on the surface of AuNP influenced the amount of proteins adsorbed 
and cellular association204. While it isn’t clear from this study how roughness was affecting 
cellular association; it is possible that the change in structure of proteins upon adsorption 
to surfaces of different roughness influences this phenomenon. It has been established that 
the secondary structure of proteins adsorbed to particles influences the type of receptors 
involved in uptake150. Thus, investigation of type of proteins adsorbed to LbL particles, 
their structure and influence of cell association should be considered to understand the role 
of surface roughness. 
6.2 Role of stiffness of anisotropic shapes in tuning phagocytic response 
Stiffness of particles has the ability to tune the phagocytic response of 
macrophages. The role of stiffness of anisotropic shapes in tuning cell interactions is an 
emerging area. From our data for rods, it is evident that reduction in stiffness of rod shaped 
particles enhances internalization by macrophages. It is possible that the macrophages are 
able to change the particle orientation during uptake or experience dynamic mobility of 
ligands owing to the reduced stiffness. Understanding the role of orientation could be 
important when multiple ligands are decorated on the surface of particles for targeted drug 
delivery applications that involve evading macrophage recognition54. The dynamic 
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mobility of ligands imparted due to reduced stiffness could help achieve desired cellular 
responses at lower ligand densities236. The investigation of these aspects would help in 
designing novel particles capable of replicating natural interfaces between cells in an 
immunological setting. 
6.3 Role of geometric presentation of ligands on phagosomal processing  
Our results indicate that geometric presentation of active ligands on varying shapes 
is inflammatory to macrophages. In another study, ovalbumin conjugated rod shaped but 
not spherical polystyrene particles were able to induce a Th2 type immune response against 
ovalbumin in vivo92. These studies suggest that there can be crosstalk between innate 
immune responses and the development of adaptive immunity. It is possible that when 
antigens are presented on varying shapes, they are processed differently by macrophages 
due to varying phagosomal activity. The physical property size was shown to affect the 
cross-presentation efficiency of ovalbumin conjugated spherical polystyrene beads by 
dendritic cells202. While it has been shown that size can influence immunological 
processing, it is unclear how shape exhibits such influence. In endothelial cells, it has been 
established that a disk shaped PS particle resided longer in prelysosomal compartment than 
spherical particles, thereby beneficial for delivering enzymes for antioxidant protection219. 
In addition, elongated shaped particles unlike spheres were shown to be oriented 
tangentially when trafficked towards the nucleus 218. The characterization of phagosomes 
and understanding the process of phagosomal protein degradation when presented on 
varied shapes can further help comprehend the varying immune responses observed in 
macrophages. Identifying these mechanisms can lead to the development of altered antigen 
presentation based either on the shape of the particle or choice of active ligand237. 
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6.4 Stability of LbL particles 
With the increasing application of LbL in immunological applications, it is crucial 
to address the stability of particles fabricated with this technique. There is very little 
evidence on long-term stability and storage of particles that are made with materials of 
varying properties like pH responsiveness, degradability. Identification of different 
cryoprotectants might be helpful in determining conditions suitable for lyophilizing these 
particles. 
6.5 Role of stiffness and shape in influencing macrophage function 
Stiffness has been identified as an important parameter in influencing the outcome 
of particle-cell interactions160. However, the role of stiffness on cellular functions is an 
emerging area, both for particulates and bulk materials. Recently, it has been established 
that stiffness of the substrate presenting antigens influences B cell activation238. 
Presentation from stiffer substrates induced greater B cell activation through enhanced 
microcluster formation and expression of activation markers. In another study, B cell 
proliferation was enhanced when antigens were presented on a soft substrate compared to 
a stiff substrate, highlighting the differences in downstream signaling upon activation 
based on B cell mechanosensing239. This mechanosensing mechanism of B cells depends 
on differences in microtubule network formation unlike actin cytoskeleton based changes 
in macrophages. While the mechanisms between these immune cells are different, it is 
possible that macrophage functions like cytokine production or antigen presentation are 
influenced during the mechanosensing based phagocytic process. From our data, rod shape 
particles functionalized with a ligand influences macrophage cytokine production during 
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the phagocytosis process. When stiffness of this shape is altered, it may not only influence 
macrophage cytokine production but also antigen presentation, based on the combination 
of these biophysical properties. Understanding the role of these properties on cellular 
functions may help design better vaccines and enhance therapeutic efficacy in macrophage 
induced autoimmune diseases like rheumatoid arthritis240. 
Ultimately, these studies have provided the biomaterials community with a novel 
technique that enables the fabrication of tunable particles and provides insight on the role 
of individual or combined particle properties in altering biological outcomes. This platform 
provides avenues for the design of advanced carriers incorporating varied physical 
properties and multiple biochemical signals for drug delivery, understanding membrane 
mechanics, or replicating native immune interfaces. The combination of particle properties 
and the choice of biochemical signal can enhance the therapeutic outcome based on the 
type of disease involved. For example, the enhanced internalization of rod capsules upon 
interaction with macrophages can have applications in rheumatoid arthritis where these 
cells are the systemic amplifiers of the disease240. Functionalization of these capsules with 
anti-inflammatory self-molecules like CD200 can attenuate inflammation by inducing an 
anti-inflammatory phenotype in macrophages241. Further, signaling ability of 
functionalized self- molecules on particles has been shown to be dependent on both the 
particle shape and rigidity232. Taking advantage of the rod capsules’ ability to deform can 
enhance the ability of CD200 to signal self and inhibit inflammation. Further, particles can 
be endowed with new functionalities, such as stimuli- responsiveness, leading to new 
strategies for immunotherapy. The integration of such tunable particle platforms with the 
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understanding of intrinsic material properties will lead to exciting applications in the field 

























APPENDIX A. ELASTICITY OF HOLLOW COLLOIDAL 
PARTICLES 
The elasticity of thin spherical shells like microcapsules has been derived analytically167 
and is known as 
 
where kshell is the shell spring constant, d is the thickness of the shell, R its radius, ⏃ the  
poisson ratio and E the Young’s modulus of the material. Thus the stiffness of spherical  
capsule is inversely proportional to the radius for the same material properties. 
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